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Abstract
High resolution voxel-based phantoms were used to assess organ doses from neutron 
external exposui'e. The segmented images of the Zubal voxel-based phantoms were 
obtained from the Imaging Science Reseai'ch Laboratories at Yale University School 
of Medicine. The phantoms data were incorporated into MCNP4C2 and MCNPX 
Monte Carlo codes. There are twofold dose calculations in this study using 
monodirectional monoenergetic neutron beams in the energy range of 10“  ^ (thermal) 
to 20 MeV, plus an extra calculation using a Maxwell fission spectrum source, under 
three different source irradiation configurations: anterior-posterior, posterior-anterior, 
and left lateral. Comparisons between the fractional dose contributions (in percent) 
from photon and neutron are taken into accoimt in the determination of the total 
effective dose. The comparison with mathematical the MIRD phantom and the 
VIPMAN voxel phantom show partial agreement for neutron effective dose 
calculations and huge differences for organs absorbed doses. The differences between 
the three phantoms neutron exposure simulations are discussed and further limitations 
of voxel-based tomographic phantom are investigated. The futui'e work at the end of 
this thesis presents a voxel-based eye phantom for high energy proton therapy with 
initial simulation of a proton beam.
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Foreword
Voxel-based anthropomorphic phantoms aie increasingly used for medical physics 
applications. The scientific community has realised the importance of constmcting 
realistic phantoms or models that represent the human anatomy in an accurate way. 
Mathematical heterogeneous models of simplified geometry have been used since the 
late sixties for internal dosimetry as well as for dose estimation from external 
radiation exposures. The major obstacle in the past was the amount of computational 
effort required not only for building-up voxel-based phantoms but also to r*un a Monte 
Carlo simulation of radiation particles in such complicated geometries. However, 
nowadays the advances in computer power and computational codes have made it 
relatively easier to simulate the human body and/or organs based on CT, MRI or 
photographic images.
The public ar*e exposed to many natmul-occurring and artificial (man-made) 
radiations in the environment. Setting the limits of radiation exposures are one of the 
primary tasks in the health physics profession, normally caiTied out by international 
organisations e.g. the International Commissiorr on Radiological Protection (ICRP) 
and International Commission on Radiological Units and Measiuements (ICRU). 
These limits are linked to basic dose quantities which can be directly measm*ed or 
computed, hi some circumstances, it is impossible or extremely difficult to make 
direct measm*ement of dose e.g. complex radiation situations. Therefore, radiation 
transport codes can provide a suitable means of dose estimation received by organ or 
tissue.
The progress made in the field of dosimetry, demands an improved realistic model of 
the human body for better assessment of the risk which aiises from radiation 
exposure. The raw data of the phantoms used in this research were obtained from 
Yale University and the phantom named Zubal after the group leader of the Imaging 
Science Research Laboratories at Yale University School of Medicine.
Among all radiation particles, neutrons are the most versatile. Neutrons plays an 
important and growing role in medical physics as a secondary product from high 
energy LINAC where the neutron contamination has to be assessed and for the
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possible use of neutron from photonuclear reaction in neutron capture therapy (NCT). 
In addition, neutron when produced from proton therapy can be used for further 
elemental analysis and quality assm*ance puiposes. Therefore, neutrons have been 
chosen in this work for dose calculations in Zubal voxel-based anthropomorphic 
phantoms. The dose from the thermal neutron energy range will be hivestigated by 
calculating the amount of energy deposition fr om neutrons and photons separately in 
each organ investigated. This reseai'ch provides a set of neutron-fluence-to-dose 
conversion coefficients for radiation protection uses. The final section of this report 
presents the outcome of the work carried out for the segmentations and the build-up of 
a high resolution eye phantom for proton therapy. The organisation of the thesis is 
outlined as follows:
® Chapter 1 provides an introduction into radiation protection system of 
effective dose concerning neutron exposure, conversion coefficients, 
anthropomorphic phantoms and Monte Carlo codes.
Chapter 2 discusses the development of the voxel-based anthropomorphic 
phantom used in this work with a description of the incorporation of the 
phantom’s data into MCNP codes.
Chapter 3 presents the methodology of dose calculations using MCNP4C2 
/MCNPX 2.4.0 codes.
® Chapter 4 gives a discussion of the results obtained fi'om monoenergetic 
neuti'ons of < lOMeV external exposure and from a Maxwell fission spectrum 
for the Zubal (head + torso) phantom. The photon contributions to dose will 
be presented in graphical and chart format. The last section of this chapter 
provides comparisons with existing similar studies with the results obtained 
from the Zubal complete model (with added aims and legs).
Chapter 5 highlights the conclusions drawn from this work and the future 
potential work. Furtheimore, a simulation of an eye model for high energy 
proton therapy will be briefly outlined in the last chapter of this thesis.
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Chapter 1
Introduction
1.1 Interactions of Neutrons; special case
Neutrons can be produced from radioisotopes but they are limited and are based on 
spontaneous fission, induced fission and/or on nuclear reactions (Knoll, 2000). Due to 
the complex nuclear reactions involved, assessment of radiation dose caused by high- 
energy radiation is often a difficult task (Nabelssi and Hertel, 1993). However, 
estimation and limitation of radiation exposure proves to be very important in radiation 
protection and facility design (Bozkurt et al., 2001). Three major sources can be 
considered when researching into neutron dosimetry:
The environment around high energy linear accelerators, which are widely used for the 
study of elementary particle physics, is known to consist of significant quantities of 
secondary radiation (mainly neutrons and muons) generated by the interactions of 
charged projectiles with shielding materials (Coulson et al., 1989). With spectra that 
range fi'om thermal energies to above GeV levels, energetic neutrons pose a radiation 
risk in the surrounding area (Kase et al., 1990). Under certain circumstances, as much as 
90% of the dose equivalent could be contributed by high energy neutrons (IAEA, 1988). 
In addition, the neutron fluence behind shielding materials for a high energy proton 
accelerator has been measured to range from thermal energies to above 200 MeV 
(IAEA, 1988; Cossairt and Elwyn, 1987).
At high altitudes, galactic and solar cosmic rays collide with oxygen and nitrogen nuclei 
in the atmosphere and produce neutrons, along with other secondary particles such as 
protons, 21-mesons, gamma rays etc. (Bozkurt et al., 2001). For airline crewmembers, 
who are considered as occupationally exposed people after recommendations of the 
ICRP (ICRP, 1991), and also for frequently frying passengers, these particles establish a 
primary source of exposure (Bartlett et al., 1997).
Interaction of cosmic rays with spacecraft shielding and materials in deep space 
exploration missions, induce secondary particles, which establish a radiation risk to the 
astronauts and the equipment inside the spacecraft (NCRP, 1989).
In common with gamma rays, neuti’ons cany no charge and the energy loss mechanism 
is different from the charged particles. When a neutron does undergo interaction, it is 
with the nucleus of the absorbing material. As a result, the neutron may either totally 
disappear and be replaced by one or more secondary radiation, or else the energy or 
direction of the neutron is changed considerably. For fast neutrons, the major form of 
interaction is elastic scattering, where the neutron shares its kinetic energy with the 
target nucleus. For slow neutrons, the significant interactions include elastic scattering 
with the absorber nuclei and a large set of neution-induced reactions occurs within this 
energy range. Elastic collisions tend to be very probable and sei-ve to bring the slow 
neuti'on into theimal equilibrium with the absorber medium before other types of 
interaction take place. This classification is rather an oversimplification on the basis of 
neutl'on energy where the division line will be about 0.5 eV {the cadmium cutoff energy) 
(Knoll, 2000): Quantitatively, neuti'on interactions are described in terms of reaction 
probabilities expressed as cross sections. For neutrons the energy range considered in 
this study (En < 20 MeV) and the cross-section infomiation is obtained from libraries of 
evaluated nuclear data sets
Energy deposition in the body due to neuti'on radiation is a complex process and 
sti'ongly energy dependent (ICRU, 1998). Neutrons undergo many interactions until they 
are fully absorbed or escape from the body producing different types of secondary 
particles during the slowing-down process. Most important variables, which determine 
the distribution of absorbed dose, at a given position in the body, are the interaction 
cross-sections, secondary particle energy spectra, and transport of the secondary 
particles from the point of interaction to that position (ICRU, 1998). Figure 1.1 shows 
some of the neutron cross-section for "^^ N drawn using MCNP code.
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Figure 1.1: Neutron cross section for Reaction types included are A(total cross- 
section), B(elastic cross-section), C(n,p), D(Average heating number), E(n,y), F(n,^H), 
G(n,^H) and H(n,a)
Since neutrons are neutral particles, their interactions with matter are not influenced by 
the attractive or repulsive Coulomb forces, hence they are very penetrating. As a result, 
varieties of secondary charged particles are produced. On the other hand, photons are 
also considerably penetrative in tissue and therefore, the production of such secondary 
photons from neutron interactions is of particular significance. Incident neutrons with 
energies up to 1 MeV produce secondary photons which deposit the major fraction of 
their energy, and hence the absorbed dose, deep in the body (90% of the absorbed dose 
is contributed by secondary produced photons from irradiation by thermal or
intermediate energy neutrons at a depth of 10 cm in the body. Whereas, it is less than 
20% of the dose at 1 MeV (Dietze and Siebert, 1994). Of particular interest is the 
emission of 2.22-MeV photons when the ^H(n,y)^H reaction occurs with the 
participation of theimalised neutrons captured in hydrogen ( around 10 % of body 
weight). As a result of Compton scattering, those photons act as the source of secondary 
photons with energies of above 1 MeV, resulting in significant energy deposition in the 
body.
A proton is another major source of absorbed dose in human tissue for the neutron 
energy of interest in this study. The reaction '^^N(n,p)^ '^ C which occurs at thermal 
neutron energies and produces protons of about 600 keV, contributes most significantly 
in the absorbed dose firom protons. Elastic scattering on hydrogen nuclei is the next 
important interaction process of neutron with energy above 1 keV, which deposits 
energy through the recoil protons produced. At energies above a few MeV, nuclear 
reactions such as (n,^H), (n,^H), (n,a) etc. occur, and the production of charged particles 
via those reactions becomes increasingly important for the deposition of energy (ICRU, 
1998).
In order to calculate the mean absorbed dose in a defined volume of a material, it is 
accepted that the dimension of the volume considered in respect to the range of particles 
resulting from secondary and tertiary processes (‘secondaries’) is sufficiently large to 
allow the use of the kerma approximation for neutron energies up to 20 MeV. The 
kerma approximation can be used wherever charged-particles’ equilibrium exists (i.e. 
charged particles are not transported firom the interaction point). It is achieved by 
multiplying the incident fluence by the appropriate kerma coefficients (ICRU, 1998). 
Recoil protons restrict the validity of this approximation, and at energies above 20 MeV, 
eiTors may result at the interfaces between tissues of largely different composition and 
density (bone surfaces, for instance) and at shallow depths. Therefore, transport of 
secondary charged particles should be considered since particle equilibrium cannot be 
achieved at energies higher than 20 MeV (the range of 20 MeV protons in tissue is about 
4 mm; does not exceed 2.5 mm at 14 MeV) (ICRP, 1996; NCRP, 1971).
1.2 Quantities for radiological protection
In its 1990 recommendation, ICRP introduces three principal protection quantities for 
use in radiological protection: the mean absorbed dose in an organ or tissue, Dt ; the 
equivalent dose in an organ or tissue, H j ; and the effective dose, E.
Absorbed dose, D, is the quotient of dE by dm, where dE is the mean energy imparted 
by ionising radiation to matter of mass dm, thus
D = f -  (1.1)dm
The unit of absorbed dose is Joule per kilogram {Jkg~^) and is refeired to as Gray (Gy»).
The primary dose limiting quantity is the effective dose, which is defined as the 
summation of the weighted equivalent doses in twelve critical organs of the body, and a 
‘remainder’ composed of additional organs (ICRP, 1991). It is given by the expression
E  =  (1.2)
T
where Hx is the equivalent dose in tissue or organ, T, and Wj is the tissue weighting 
factor for tissue, T.
Equivalent dose, Hx, is the absorbed dose in an organ or tissue multiplied by the relevant 
radiation weighting factor (ICRP, 1991), and is obtained by
(1*3)
R
where D x,r is the absorbed dose averaged over the tissue or organ, T, due to radiation R, 
and w r is the radiation weighting factor for radiation R. The unit of equivalent dose is J  
kg~  ^and its special name is Sievert (Sv).
The Wr is a dimensionless factor wliich accounts for the quality or biological 
effectiveness of different types of radiation relative to y rays. The values of radiation 
weighting factors, w r , are energy-dependent and do not take into account the 
disturbance of the radiation field inside the body, w r  for certain types of radiation is 
based on experimental values of its relative biological effectiveness (RBE) (NCRP 
1993). The relative biological efficiency of any given radiation has been defined by 
comparison with y radiation from radium filtered by 0.5mm of platinum (ICRP 92
2003). It can be expressed numerically as the inverse of the ratio of the doses of the two 
radiations required to produce the same biological effect under the same conditions. 
The RBE is related to linear energy ti'ansfer (LET) of the radiation that is the energy loss 
per unit path length (keV/pm) as shown in Figure 1.2. At low LETs the RBE shows an 
increase proportion with the increase of LET because as LET increases the number of 
ionisations in a cell and the particle track will increase. This will add to the cell killing 
efficiency of the radiation. With further increases of the LET, an optimum cell-killing 
efficiency will be reached and an extia energy transfer by radiation will not be needed to 
destroy cells and the RBE will drop as a result (Turner 1995)
OPTIMUM RANG] OVER KILLINGLow LET High LET
II
LET (Arbti)
Figure 1.2: schematic representation of Relative Biological Effectiveness (RBE) for cell 
killing as a function of Linear Energy Transfer (LET) of charged particle [Turner 1995]
Table 1.1: Values for radiation weighting factors [From ICRP 60 (1991)].
Types and energy range of radiation Radiation weighting 
factor, Wr
Photons, all energies 1
Electrons and muons, all energies 1
Neutrons, energy
<10keV 5
lO-lOOkeV 10
100 keV -2M eV 20
2 - 2 0  MeV 10
> 20 MeV 5
Protons, other than recoil protons, energy > 2 MeV 5
Alpha particles, fission fragments, heavy nuclei 20
Table 1.1 presents the values of w r used for radiological protection puiposes 
recommended by the ICRP. Weighting factors for neutrons can be chosen from either a 
step function, or, when calculation of weighting factors for neutrons requires a 
continuous function to avoid discontinuity, the following approximation (smooth 
function) can be used:
=5 + 17exp -{In(2^J}' (1.4)
where En is the neuti'on energy in MeV. The values of Wr for neutrons taken from ICRP 
Report 60 (1991), are shown in Figure 1.3 which also shows the potential modification 
of radiation weighting factor taken from ICRP publication 92 (2003). This function can 
be expressed as:
w^ = 2 .5 (2 - exp(“ 4E;„) + 6 exp(-ln(EJ„)^/4) + exp(-ln(E'„ /30)^ /2)} (1,5)
neutron radiation weighting factors
2 5  1
 IC RP60 S tep  function
—  IC RP60 co n tin u o u s  function 
 IC R P92 proposed modification
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Figure 1.3; Radiation weighting factors for neuti’ons as a function of neutron energy. 
Solid line represents Table 1.1 step-function data, and dashed line represents the smooth 
function values derived using Equations (1.1) and (12) [  redrawn from ICRP 60 (1991)
when comparative lai'ger tissue volumes, e.g. mice, rats or humans are irradiated, the 
situation becomes increasingly more complex as a result of the mixed radiation field in 
the body. The relative contribution of secondary photons increases with the size of the 
receptor volume and with decreasing energy of the neutron. The wr for neutr on energies 
less than 1 MeV, as described by equation (1.4), is not consistent with tire type of 
neutron interaction at tliis energy range. Therefore, the proposed modification equation 
(1.5) preserves the wr at 1 MeV and reduces it for lower neutron energies.
The tissue weighting factor, wt, is a factor by which the equivalent dose to a tissue or 
organ is multiplied by, in order to accoimt for the relative stochastic detriment resulting
from the exposure of different tissues or organs (ICRU, 1998). The values of wt used 
for radiological protection purposes recommended by the ICRP Publication 60 (1991) 
are given in Table 1.2. The Commission recommends weighting factors for 12 tissues 
and organs (considering testes and ovaries as one = gonads), plus a so-called 
‘remainder’, which is composed of another ten organs. The ti'achea replaced the upper 
large intestine ICRP Publication 66 (1994), which ear lier was part of the remainder, but 
actually is aheady included in the colon in the main list (Kramer et al., 2003).
Table 1.2; Tissue weighting factors [From ICRP 60 (1991) and 26 (1977)].
Tissue or organ Tissue weighting factor, wt
ICRP 60 (1991) ICRP 26 (1977)
Gonads 0.20 0.25
Bone marTow (red) 0.12 0.12
Colon 0.12 -
Lung 0.12 0.12
Stomach 0.12
Bladder 0.05
Breast 0.05 0.15
Liver 0.05
Oesophagus 0.05
Thyroid 0.05 0.03
Skin 0.01 -
Bone surface 0.01 0.03
Remainder: (adrenals, brain, kidney, 
skeletal muscle, pancreas, small 
intestine, spleen, thymus, and uterus)
0.05 0.30
1.3 Conversion coefficients for neutrons
A ‘conversion coefficient’ links the protection and operational quantities to physical 
quantities, characterising tire radiation field (ICRP, 1996; ICRU, 1998). Conversion
coefficients are one of the most helpful health physics quantities in assessing risk for 
population exposure to external radiation, and in facilitating shielding design (ANS, 
1991; ICRU, 1998). In practice, tlie physical quantities that are usually calculated or 
used ai*e the tissue-absorbed dose (D t), air kerma free-in-air (Ka), and particle fluence 
(0)  (particle.cm'^). For example, the average absorbed dose to the organ exposed to the 
radiation field can be related to a particular fluence O by
(1.6)
where D t,r  is the average absorbed dose to tissue, T, due to radiation type R . C%, R is the 
fluence-to-dose conversion coefficient (Gy.m^) for tissue T and radiation type R.
The Joint Task Group (ICRP, 1996; ICRU, 1998) reviewed organ dose data using the 
calculations (of seven groups of authors) listed in Table 1.3. The various authors 
provide conversion coefficient data for organ absorbed doses and effective doses, 
utilising six different iiTadiation geometries (as shown in Figure 1.4):
(a) Anterior-posterior (AP): Ionising radiation is incident on the fr'ont of the body in a 
direction orthogonal to the long axis of the body.
(b) Posterior-anterior (PA): Ionising radiation is incident on the back of the body in a 
direction orthogonal to the long axis of the body.
(c) Right and (d) Left lateral (RLAT and LLAT): Ionising radiation is incident from 
either side of the body in a direction orthogonal to the long axis of the body.
(e) Rotational (ROT): The body is irradiated by a parallel beam of ionising radiation 
fr om a direction orthogonal to the long axis of the body, which rotates at a unifoim rate 
around the long axis.
(f) Isotropic (ISO): is defined by a radiation field in which the particle fluence per unit 
solid angle is independent of direction (ICRU, 1998).
Basically, the calculation procedure of the dosimetric quantities and the conversion 
coefficient for the radiation type that links them to the radiation fields usually employ an 
anatomical model (or phantom) for the human body. Calculations are carried out 
assuming that the whole body is irradiated by broad unidirectional or plane parallel 
beams. Several types of the so-called ‘standard’ Monte Carlo codes were used in the
10
past, such as LAHET, MCNP, MORSE-CG, and SAM-CE. Some other special codes 
such as by JAERI and PTB were developed and operated by Yamaguchi (1993) and 
Hollnagel (1990), respectively. Six groups of authors have used the MCNP code, while 
the kerma approximation was used by all authors for neutron energies below 20 MeV. A 
summary of the energy groups usually referred to as energy bins (which differed widely 
among the various authors) is given in Table 1.3.
(a) AP (b) PA (c) RLAT (d) LLAT
(e> ROT (f) ISO
Figure 1.4: Six different irradiation geometries for which ICRP (1996) and ICRU 
(1998) provide conversion coefficient data. [From Chao et al. (2001)].
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Table 1.3: Summary of calculation of the conversion coefficients for protection 
quantities for neutrons [From ICRU 57 (1998)].
Authors Codes/ Database/ models Protection 
.quantities 
(Dn H t» E)
Irradiation
Geoni.
Energy range energy points
Morstin et 
al. (1992)
Monte Carlo code: MCNP 
Neutron cross sections: 
ENDF/B-IV 
Model: EVA
All AP/PA
LLAT
RLAT
Thermal 
to 20 MeV
33
Nabelssi and
Hertel
(1993)
Monte Carlo code: MCNP 
Neutron cross-sections:
ENDF/B-V & RMCCS-MCNP 
Kerma coefficients:
Caswell et al. (1980)
Model: PENELOPE (male, female)
All AP/PA
LLAT
RLAT
ROT
10 MeV to 
19 MeV
14
Leuthold et 
al. (1992)
Monte Carlo code: SAM-CE 
Neutron cross-sections: 
ENDF/B-IV 
Kerma coefficients:
ICRP 26 (1977)
Model: ADAM and EVA
All AP/PA
LAT
ROT
10 eV to 
13.5 MeV
14
Leuthold et 
al. (1992)
Monte Carlo code: MCNP 
Neutron cross-sections: 
ENDF/B-IV 
Kerma coefficients:
White et al. (1992)
Model: ADAM and EVA
All AP/PA
LLAT
RLAT
ROT
ISO
Thermal 
to 20 MeV
19
Yamaguchi 
(1993, 1994)
Monte Carlo code: JENDL-3 
Kerma coefficients:
Caswell et al. (1980)
Model: MIRD
All AP/PA
RLAT
ROT
ISO
Thermal 
to 18.3 
MeV
16
Stewart et 
al. (1993)
Monte Carlo code: MCNP 
Neutron cross-sections:
ENDF/B-F 
Kerma coefficients:
Caswell et al. (1980)
Model: PENELOPE (male, female)
All AP/PA
LAT
1 keV to 
20 MeV
17
Hollnagel 
(1990, 1992, 
1994)
Monte Carlo code: HL-PH 
Neutron cwss-sec//o«s;ENDF/B-IV 
Kerma coefficients: Caswell et al.(1980) 
Model: ADAM and EVA
All AP/PA
LAT
ROT
ISO
Thermal 
to 20 MeV
32
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Schumacher et al. (1994) have mentioned that the values of the conversion coefficients 
calculated by the various authors are significantly influenced by the number and width 
of energy bins. These differences become greater for deep-lying organs and at neuti'on 
energies below 1 keV, where the neutron degradation process and the contribution from 
secondary photons are more important (ICRU, 1998). In the case of thermal neuti'on 
energies, energy deposition needs special consideration because neutron scattering is 
strongly dependent on the molecular binding of hydrogen and the chemical composition 
of the material where the scattering occurs.
The kerma of tissue due to various types of interactions per unit fluence of neutrons is 
computed as shown graphically in Figure 1.5. Both the tissue kerma coefficient and the 
^H(n,y)^H and ^^ N(n,p)^ "^ C reaction cross-sections are inversely proportional to the 
neutron energy. Hence, hydrogen binding and the precision with which the theiinal 
energy distribution is described play a very significant role in the determining the mean 
kerma coefficient fiom thermal neutrons and the secondary photon fluence (ICRU, 
1998).
1.4 Anatomical body models
A computational model of human anatomy is a mathematical representation of the 
external envelope of the human body shape, together with the boundaries of the internal 
organs. The volumes that the organs define are filled with a medium that has chemical 
elements composing the tissue in a coixect proportion as well as the density (Caon,
2004). Normally, this infoimation is tabulated in sources such as ICRU reports 44 and 
46 and ICRP publications 23 and 89. Basically, there are two kinds of anatomical body 
models, mathematical models and tomographic imaged based models or voxel 
phantoms. Both kinds are refeiTed to as anthropomoiphic phantoms, meaning pertaining 
to human foim or attribute. Clearly, tomographic voxel-based phantoms can be argued 
to be more anthropomoiphic than the mathematical models. However, neither is 
anthropomorphic in tei-ms of accounting for dose reconstiuction for the individuals’ past 
radiation exposure (Huh and Bolch, 2004). An overview for both models is provided in 
the following sections.
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Figure 1.5 Contribution of the various types of neutron interactions in tissue to the 
Kerma of tissue [Redrawn from NCRP (1971), Tzortzis (2003)]
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1.4.1 Mathematical model
As dosimetric quantities cannot be directly measured in the human body, mathematical 
heterogeneous models of simplified geometry (combinations and intersections of planes, 
circular and elliptical cylinders, spheres, cones, etc.) were used to describe the size and 
form of the body.
r m
(a) (b) (c)
Figure 1.6. (a) The original MIRD-based mathematical adult male model showing 
exterior view, and skeleton and internal organs [From Xu et al. (2000)]. (b) The MIRD 
adult hermaphrodite phantom [From Jarry et al. (2003)]. (c) ADAM and EVA MIRD5- 
type phantoms [From Kramer et al. (2003)].
The first anthropomorphic model of an adult male which contained ovaries and uterus, 
was introduced at Oak Ridge Laboratory for the Medical Internal Radiation Dose
15
(MIRD) Committee of The Society of Nuclear Medicine (Fisher and Snyder, 1967, 
1968). The model, known as the MIRD Phantom (Figure 1.5), was further developed by 
Snyder et al. (1974, 1978) during the compilation of the report of the Task Group on 
‘Reference Man’ (ICRP, 1975), and became the basis for various derivations 
representing infants and children of various ages (Cristy, 1980); gender-specific adult 
phantoms known as the ‘Adam’ and ‘Eva’ (Kramer et al., 1982); a pregnant female adult 
phantom (Stabin et al., 1995); and revised head and brain models (Bouchet et al., 1996). 
The original MIRD phantom can be analytically described in three sections: an elliptical 
cylinder representing the arm, torso and hips, a tr uncated elliptical cone representing the 
legs and feet, and an elliptical cylinder representing the head and neck so as to simplify 
the mathematical equations and minimise the computation time (Snyder et al., 1978; 
ICRP, 1987, 1996), Later, improvements have led to a whole ‘family’ of models of both 
sexes and various ages (Cristy and Eckeiman, 1987). Most of the dosimetric values 
published by the ICRP (ICRP, 1996) and the ICRU (ICRU, 1998) have been derived 
using the MIRD5-type phantom.
1.4.2 Tomographic voxel-based model
The scientific community has begun to realise that the human anatomy is too 
complicated to be realistically modelled with oversimplified anatomical characteristics 
and a limited set of equations, essentially resulting in the compromise of many 
anatomical details (Xu et al., 2000). Today’s computers are powerful enough to allow 
the study of image-based and realistic body models with the aid of advanced imaging 
techniques, such as Computed Tomography (CT) and Magnetic Resonance Imaging 
(MRI), visualising the internal structures of the body and storing the images in versatile 
digital formats. The first tomographic or voxel phantoms were introduced by Gibbs et 
al. (1984), and independently by Williams et al. (1986). The latter extended their effort 
to cover the case of infant (‘BABY’) and children (‘CHILD’) voxel phantoms (Zankl et 
al., 1988; Veit et al., 1989), and a ‘voxelised’ version of the Alderson-Rando phantom 
(Veit et al., 1992), and gradually, a whole family of voxel phantoms was created (Zankl 
and Witmann, 2001; Petoussi-Henss et al., 2002). Segmented CT and MRI data of a 
patient scanned from head to mid-thigh were provided by Zubal et al. (1994a, 1994b,
16
1995), and a voxel phantom called NORMAN based on MRI data from a healthy 
volunteer were introduced by Dimbylow (1995). Caon et al. (1997) developed 
ADELAIDE, a voxel phantom of a young girl, and Saito et al. (2001) presented 
segmented data of a patient’s whole-body CT scan, while Xu et al. (2000) provided 
segmented colour photographs of a visible human male in constructing the VIPMAN 
(Visible Photographic MAN) voxel phantom ( Figure 1.6)
(a) Cb) (c)
Figure 1.7: (a) The image-based VIP-man model created using the plotting features of 
MCNPX [From Bozkurt et al. (2001)^ (b) Frontal view and centre vertical plane cut of 
the Zubal phantom (MAX phantom), which includes a representation of some of the 
organs and tissues mentioned in Table X [From Kramer et al. (2003)1. (c) Sagittal and 
coronal view of the part of the Zubal phantom used in this study, i.e. from the crown of 
head up to the mid thigh [From Zubal et al. (1994)]
17
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Tomographic voxel-based phantoms have been used with Monte Carlo techniques to 
calculate absorbed dose to human organs and tissues irradiated with ionising radiation 
for radiation protection purposes, in radiography and for dosimetry of internal 
radioactive exposure. In addition, to radiotherapy which uses a small voxel model 
normally defining a small region of interest, whole body voxel tomographic models 
have also have been used to calculate the specific energy absorption rate from exposure 
to non-ionising electr*omagnetic fields (Dimbylow, 1995). The large numbers of images 
and the time spent on segmenting medical images necessary to build a voxel model are 
the major draw-backs in the development of voxel models. Tablel.4. shows some of the 
21 whole or partial body existing models and more is being prepared. The reason behind 
the continued development of voxel-based models is the hope that gr eater realism with 
which human anatomy is represented in voxel computational 3D models (Coan 2004). 
This allows for more accurate organ doses to be calculated as compared to using MIRD 
models. Furthermore, as a result of using voxel-based models, a better definition and 
understanding of relations between basic absorbed dose to organs or tissue and the other 
radiation protection quantities i.e. effective dose can be achieved ( Xu et al 2004.)
1.5 Monte Carlo techniques
The Monte Carlo technique is a well studied technique for solving problems of 
stochastic statistical nature such as radiation transport. This technique can be considered 
as theoretical experiments that substitute impossible or difficult physical experiments. 
Figure 1.7 shows a flow chart of a typical procedure using Monte Carlo methods. 
Monte Carlo does not solve an explicit equation unlike other deterministic transport 
methods. By conti’ast, it obtains answers by simulating individual particle histories and 
recording some aspects (tallies) requested by the user of their average behaviour. The 
individual probabilistic events that comprise a statistical process, such as the interaction 
of nuclear particles with materials, are simulated sequentially. The number of trials 
necessary to adequately describe the phenomenon is usually quite large. The whole 
process of statistical sampling requires the selection of random numbers, analogously to 
thi’owing a dice in a gambling casino (hence the name ‘Monte Carlo’), in order to cany 
out a theoretical but realistic representation of the experiment in the case of particle
19
transport. Each particle emitted from a source is followed throughout its life to death in 
a terminal category, such as complete absorption or escape. The outcome at each step of 
its life is determined by physical rules and probability distributions, which are randomly 
sampled using transport data that govern the processes and materials involved. Particle 
distributions become better known as an increased number of histories are followed, and 
the quantities of interest are appropriately tallied along with their statistical precision 
(uncertainty).
UPDATE TALLY
STOP
TERMINATE HISTORY
UPDATE TALLY
ALL PARTICLE RUN?
UPDATE STATE 
VECTOR
START NEW 
HISTORY
CHOOSE INTERACTION 
TYPE AND THE OUTCOME
CHOOSE STAGE 
-VECTOR
-ENERGY
-POSITION
CHOOSE
DISTANCE TO NEXT INTERACTION (dc ) 
DISTANCE TO SURFACE CROSSING ( ds )
DOES PARTICLE COLLIDE BEFORE 
LEAVING REGION OF INTEREST 
( dc < ds)
IS PARTICLE SIGNIFICANT? 
(CHECK FOR ENERGY CUTOFF, 
WEIGHT CUTOFF, ETC.)
Figure 1.8: Flowchart for simulating particle transport using the Monte Carlo technique 
[adapted from Chao 2001]
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There are several Monte Carlo codes available for radiation transport. In this study, the 
Monte Carlo code MCNP4C2 (Briesmeister, 2000) and the extended version of this 
code, MCNPX (Waters et al 2002) was used to simulate the radiation transport and 
interaction. Using the MCNP code is relatively convenient for several reasons {Chao
2 0 0 7 ;:
• No coding is necessary. All source distribution, energy and time distribution, 
position and direction as well as the starting source particle can be defined in the 
“input file”
• MCNP provides a very powerful tool to define complex geometry, with a user 
friendly feature
• A user can change how the history is recorded using a variety of tallies like 
average flux or energy deposition
• MCNP provides a normalized result with statistical uncertainties
MCNP uses continuous-energy nuclear and atomic data libraries, primarily originating 
from the Evaluated Nuclear Data File (ENDF) system, the Evaluated Nuclear Data 
Library (ENDL), and the Activation Library (ACTL) compilations. Information for 
approximately 100 different isotopes are provided along with over 500 neutron- 
interaction tables. Different evaluations, variable temperature regimes, and different 
processing tolerances result in the existence of multiple tables for a single isotope. The 
MCNP data package provides cross sections for nearly 2000 dosimetry or activation 
reactions, which involve over 400 target nuclei in the ground and excited states. At low 
neutron energies, chemical (molecular) binding and crystalline effects become 
important, and data for those phenomena are also provided in theimal data tables, which 
can be used along with the S(a,P) scattering treatment {Briesmeister, 2000)
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Chapter 2
Development of Zubal voxel-based phantom
2.1 Voxel-based anthropomorphic phantom
In order to build a body model fi*om tomographic images, the quality of the original 
images is a crucial part for accurate representation of the body organ (Bozkurt et al., 
2001). A slice of image, when computerized, is represented by a matrix of pixels in 
two dimensional geometry. The voxel elements (tlu'ee dimensional volumes) are 
obtained by multiplying the pixel size by the slice thickness. Figure 2.1 shows the 
main steps in constmcting a voxel-based body model for radiation dosimetry 
puiposes.
Perform
segmentation
Obtain image 
Slices
Import the data to 
Monte Carlo code
Assign physical 
properties Voxel-based 
body model
Figure 2,1: Steps involved in constructing a voxel-based body model, [adapted 
partially from Xu et al 2004].
After obtaining the tomographic images, the first step involves segmentation and 
sorting procedures. These processes separate each organ and tissue from the original 
image either by manual segmentation or using semi-automated software. The second 
step involves assigning the labelled voxel by its physical propeifies based on the 
elemental composition for each organ or tissue. These voxels are grouped together to 
make up the voxel-based body model which, by the final stage, represent a human 
body ready to be imported to the Monte Cailo code for simulation of the desired 
radiation transport.
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2.2 Development of Zubal voxel-based phantom
The anthropomorphic phantom used in this study was produced by a research group 
led by Dr. George Zubal of the Imaging Science Research Laboratories at Yale 
University School of Medicine {Zubal et a l, 1994a), who identified and segmented 
CT torso and MRI head slices of two living human males, using high-resolution 
bitpad and display {Evans et a i, 2001). Figure 2.2 shows an example of a model 
image before and after partial segmentation of kidneys. The manually identified and 
segmented 129 X-ray CT transverse slices were used to create a computerised 3- 
dimensional volume array modelling all major internal structures of the body. 
Organs or tissues used to construct the Zubal model included adrenals, bladder, 
oesophagus, kidneys, lungs, liver, pancreas, prostate, skeletal components, skin, 
spleen, stomach, small and large intestine, testes, thyroid, and other organs. The 
final list consists of those organs defined as ‘critical’ and for which ICRP has 
assigned radiation-weighting factors {ICRP, 1991), as well as of other organs 
considered as important in respect of their biomedical applications. The completed 
list of the Zubal model organs is given later in this chapter. The original X-ray CT 
images were reconstructed in a 512x512 matrix with a resolution of 1 mm in the x-y 
plane. The z-axis resolution is 1 cm from neck to mid- thigh and 0.5 cm from neck 
to crown of the head.
Figure 2.2. Transaxiale CT scans of the abdomen at the level of kidneys (left) 
before (CT-image), and after partial segmentation of kidneys and spinal cord 
vertebra (right).
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The final torso and head phantom is inteipolated to create a 128x128x243 byte 
volume with isotropic voxel dimensions of 4 mm. A 3D median filter was run over 
the data set to remove ‘boxiness’ caused by duplicating slices. This volume array 
represents a high-resolution model of the human anatomy and can serve as a voxel- 
based anthropomorphic phantom suitable for many computer-based modelling and 
simulation calculations (Zubal, 2003), Later, the arms and legs segmented fiom the 
Visible Man’s (NLM, 2003) colour' cross-sections have been added by (Stuchly 1996) 
to the torso phantom, which has been resampled to achieve a 3.6-mm cubic voxel 
size (‘MANTISSUE 3-6’).The straightening of the aims was done as follows: 
the lower parts of the arms were segmented by manual region di'awing in transversal 
slices. Each of these aim hnages was then rotated in 3D and reinserted into the 
original phantom. The rotation angles were determined on the basis of the 
appearance in sagittal, coronal and transversal slices and projections, so that the aim 
contours were sufficiently smooth and that no part of the aims interacted with the 
remainder of the body. Prior to reinserting the rotated underarms into the original 
phantom, the five uppermost slices of each arm was interpolated to account for the 
oblique section surface that resulted at rotation. A few slices over the elbow were 
rotated sepai'ately to make the elbow bone (olecranon) point backwards. Some 
processing of each arm was also done using standard morphology operations and 
interpolation, to assure that the veins and skin were continuous over the slices and 
that the appearance of bony structures was sufficiently smooth. Nearest neighbour 
interpolation was used Üuroughout to maintain the organ codes and to not introduce 
new values into the phantom. Finally, in this version of the Zubal phantom with the 
aims along the sides of the body was achieved (Sjogreen, 1998) whilst maintaining 
the 3.6-mm cubic voxels (‘VOXTIS S8’).
2.3 Adaptation of the image data into the MCNP codes
The ‘raw’ data files downloaded fiom the Yale website (Zubal, 2003) include all of 
the valuable anatomical data for the phantom construction in 129 CT slices for the 
Zubal head-torso part under the file name (voxel_man.dat) and the complete model 
under the file name (‘VOXTIS 88’). The head-torso part was adapted into 
MCNP4C2 code and in further analyses the complete body model was adapted into 
MCNPX due to its powerful capabilities and for faster files execution. Both codes
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were used independently for different studies in the work as indicated for each 
calculation. In the following section the discussion will concern the adaptation of the 
phantom data into MCNP4C2.
2,3.1 MCNP4C2 head-torso model
The data is represented as 128 %128 x 243 one-byte array, each of the 243 image 
slice consists of 128 rows x 128 columns of integer numbers in sequence according 
to the different colour-intensity contrast of the various organs/tissues in the 
segmented images (as shown in Figure 2.3(b)). A C-programme (appendix A) was 
written on the basis of the colour-intensity contrasts between the various identified 
and segmented tissues (or organs). The first objective of the C-programme was to 
bring the file’s data to the required foimat in order for the MCNP code to recognise 
and run it. In an MCNP input file, the cell, surface, and data cards must all begin 
within the first five columns. Blanks in the first five columns indicate a continuation 
of the data from the last named cai'd (Briesmeister, 2000). The C-programme 
arranges the numbers included in each image slice within columns 5-80, indicating 
in this way a continuation of the data provided, imtil information for all model slices 
are displayed under the same card in the input file as one cell, (i.e. hexahedra lattice 
cell). The second objective was to ‘compress’ the input file and reduce its size as 
much as possible. Since each pixel for the same organ or tissue is labelled with a 
unique identification number (ID), normally the adjacent pixel carries the same ID. 
Each character (e.g. ID niunber) is represented by two bytes and the total size of the 
file with out compressing will be in megabytes which can not be handled by 
MCNP4C2 code. Fortunately, MCNP enables the use of the nR feature, which 
essentially means ‘repeat the immediately preceding entry on the card n times’ 
[Figure 2.3(c)], The C-program arranged the shortlist group o f ID numbers using 
two bytes for each character. Thus, a maximum of 24 ID or group of IDs 
representing the organ or tissue as an index number for the lattice array on each line 
of lattice card used in MCNP input file was achieved. For example, if  nmnber 1 has 
to be repeated 4026 times before another number, such as number 2, is introduced, 
then the nR feature facilitates the cai*d preparation by simply writing 1 4026R 2, 
instead of writing 1 1 1 1 1 1 1  {4016 times} 1 1 1 1 1 2 .  The repeated use of this
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(a)
1 1 1 1 1 1 1 1 1  
1 1 1 1 1 1 1 1 1  
1 1 1 1 1 1 1 1 1  
1 1 2 12 30 40 46 
0 0 0 0 0 0 0 0 0  
26 42 58 64 64 65 
0 0 0 0 0 0 0 0 0  
64 64 65 69 71 72 
0 0 0 0 0 0 0 0 0  
66 71 72 72 72 72 
0 0 0 0 0 0 0 0 0
71 71 70 70 71 69
72 68 65 64 68 69
etc.
I l l  
111 
111 
50 56 
0 0 0 
65 64 
0 0 0 
72 72 
0 0 0 
72 7 
0 0
68 e
69 e
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
56 47 28 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 1 1 6  26 32 38 37 32 25 18 1 0 2
64 64 64 64 64 4 8 1 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 20 45 61 64 64 64 64 64 64 64 64 64
72 71 67 64 64 64 64 63 36 1 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 19 52 64 64 64 64 66 68 70 71
(b)
1 4026r 2 3 r 1 2 5 r 1 120r 2 7 r 1 H9tr 2 8 r 1 H 7 r 2 lOtr 1 U S r 2 IQr
1 11%- 2 U r  1 1 1 *^1- 2 U r  1 li% - 2 12r 1 U 4 r 2 12r 1 ii% - 2 13r 1 ii% - 2 
13r 1 U 3 r 2 13r 1 U 3 r 2 13r 1 U 3 r 2 13r 1 U 3 r 2 13r 1 U 3 r 2 13r 1 
U 3 r 2 13r 1 U 3 r 2 12r 1 U 4 r 2 12r 1 U 4 r 2 12r 1 U 4 r 2 U r  1 UGr 2 
IQr 1 U 7 r 2 8 r 1 U 8 r 2 7 r 1 123r 2 I r  1 6012r 2 5 r 1 120r 2 6 r 1 U 9 r 2 
9 r 1 U 6 r 2 2 r 3 3 r 2 3 r 1 U S r 2 2 r 3 5 r 2 3 r 1 U 4 r 2 I r  3 7 r 2 2 r 1
U 4 r 2 I r  3 8 r 2 2 r 1 ii% - 2 2 r 3 8 r 2 2 r 1 U 2 r 2 I r  3 IQ r 2 I r  1 U 2 r 2
I r  3 IQ r 2 I r  1 iiT r  2 I r  3 U r  2 I r  1 iH f  2 I r  3 U r  2 I r  1 m -r  2 I r  3 
U r  2 I r  1 i i i r  2 I r  3 U r  2 I r  1 iiT r  2 I r  3 U r  2 I r  1 UOr 2 2 r 3 U r  2 
I r  1 U Qr 2 2 r 3 U r  2 I r  1 UQr 2 2 r 3 U r  2 I r  1 UOr 2 2 r 3 U r  2 I r  1
UQr 2 2 r 3 IQ r 2 2 r 1 lU r  2 I r  3 IQr 2 2 r 1 lU r  2 2 r 3 8 r 2 3 r 1 U lr  2
3 r 3 7 t 2 2 r 1 U 3 r 2 2 r 3 5 r 2 3 r 1 U 4 r 2 12r 1 U 5 r 2 IQ r 1 U 8 r 2 7 r 1
etc.
(c)
Figure 2.3. (a) Slice through the segmented torso (b) Example of the original 
anatomical data based on the different colour-intensity contrast of the various 
organs/tissues in the segmented images, (c) Another example of anatomical data as 
rearranged and ‘compressed’ by the C-programme for use with the nR feature of 
MCNP.
26
feature allows the modified final input file containing data for all the 129 model slice 
to be even smaller in size than any of the original files containing data for a single 
model slice. A final reduction of file size achieved was 832 kilobytes ( more than 10 
times smaller original file size ~ 11MB), which the MCNP4C2 code can handle.
The basic structure used in the input file is a 4-mm voxel. Each voxel is assigned 
with a unique ID number according to its material properties such as elemental 
concentration and density, and voxels characterised by the same ID number form 
different organs, which in turn make up a lattice to construct the whole body. Sixty- 
six such ID numbers were assigned, as shown in Figure 2.4. MCNP provides the 
built-in ‘repeated structure’ feature that allows the use of repetition in the entire 
model voxels incorporated into the array defined.
B
(a)
(b)
S 3 -
■
H  Tissue 1 — A 
B  Tissue 2 — B 
E l Tissue 3 — C
Figure 2.4. Left: Example of a generic geometry (b) composed by single cells (a), 
using the MCNP ‘repeated structure’ feature [From Yoriyaz et al. (2000)]; Right: 
Transverse slice of the Zubal phantom at the height of the liver and stomach, plotted 
using the MCNP plotting features. Voxels characterised by the same ID number 
form different organs, which in turn make up a lattice to construct the whole body.
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Table 2.1. Organs available in the torso-head Zubal voxel phantom. Highlighted are 
the cells and corresponding organs for which fluence-to-dose conversion coefficient 
calculations are performed in this work according to (ICRP 1991) recommendations
Cell Organ Cell Organ
3 Skin 34 Rib cage / sternum
4 Slcull 35 Bone maiTOW in rib cage/stemum
5 Brain 36 Thyroid
6 Cerebral flax 37 Bone marrow in spine
7 Skeletal muscle 38 Lungs
8 Sinuses / Mouth cavity 39 Bone marrow in spine
9 Fat 40 Heart
10 Cartilage 41 Diaplnagm
11 Eye 42 Liver
12 Lens 43 Stomach
13 Optic nerve 44 Spleen
14 Pons 45 Colon
15 Cerebellum 46 Lesion
16 Blood pool 47 Small bowel
17 Jaw bone 48 Pancreas
18 Hard palate 49 Adrenals
19 Medulla oblongata 50 Kidneys
20 Teeth 51 Gas (bowel)
21 Spinal cord 52 Urine
22 Tongue 53 Gall bladder
23 Pharynx 54 Pelvis
24 Spine 55 Bone maiTow in pelvis
25 Dens of axis 56 Fluid (bowel)
26 Spinal canal 57 Faeces
27 Bone marrow in spine 58 Bladder
28 Trachea 59 Rectum
29 Aim bones 60 Leg bones
30 Bone marrow in right arm 61 Bone marrow in leg bones
31 Bone marrow in left arm 62 Prostate
32 Bone marrow in spine 63 Testes
33 Oesophagus
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Thus, the repeated structure feature makes it possible to describe only once the cells 
and surfaces of any structure that appears more than once in a given geometry.
This unit is replicated at other x,y,z location by using the ‘LIKE m BUT  ’ construct 
on a cell card, also providing the opportunity to make a distinction between other 
specific details (e.g. material, density, etc.) that make each cell different from the 
basic cell used for replication. Each organ is represented by one different cell, which 
in turn is filled by a different universe. A complete list of the human organs available 
for dosimetric calculations in the input file used along with their corresponding cell 
numbers is provided in Table 2.1. Highlighted are the cells and corresponding organs 
for absorbed dose calculations performed in this work. Sagittal and coronal slices of 
the Zubal phantom as drawn using the plotting features of MCNP are illustrated in 
Figure 2.5.
\
Figure 2.5. Sagittal and coronal slices of the Zubal phantom (head + torso) as drawn 
using the plotting features of MCNP.
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As the mass and volume of the organs of interest are known, the VOL card was used. 
The VOL card provides an alternative way to enter manually the volumes required 
by tallies for the dosimetric calculations, and these are the values that are used for 
the simulation, instead of the code-calculated ones. The number of entries must be 
equal to the number of cells in the problem, and the nJ  feature of MCNP is used to 
skip over cells for which calculations are not performed.
2.3.2 Adaptation of the image data into the MCNP X codes
The complete phantom data (Zubal with arms and legs added) imder the file name 
(‘VOXTIS S8’) was adopted into the MCNPX code. MCNPX is a general-purpose 
Monte Carlo N-Particle code that extends the capabilities of the Los Alamos MCNP 
code. The main features of the MCNP code are the same as the MCNPX code (i.e. 
the constrain of the input file), the sources option and tallies plus extra features (e.g. 
running many files using patch files and more cross-section data libraries). The code 
allows the transport and interaction of neutron, photons, electrons, protons and heavy 
charged particles in a wide range of energies.
The main two steps which were explained in tire previous section were used to 
implement the segmented image data into the MCNPX code. The following 
discussion describes the differences on the MCNPX input file construction. The 
same logic used by the C-program to construct the MCNP input files was used by 
more powerful programming language called IDL (interactive data language) which 
allow for pre and post processing of the input files. The phantom imder the file name 
(‘VOXTIS S8’) consists of 192x96x498 3.6mm cubic voxels, each labelled by one 
of the 86 organ identification nmnbers (IDs). Instead of replicating the basic cell 
using the "LIKE m BUT  ’ in the case of the MCNP4C2 files, the original organ IDs 
became the universe numbers in the MCNPX input file whilst a sequential listing of 
the whole phantom became the universe numbers in the fill cai'd (Alghamdi et al 
2004). A complete list of the organs IDs with their masses, volumes and the 
corresponding rmiverses is provided in Table 2.2. A sample of the IDL code is given 
in appendix B. After removing the extraneous layers of voxels outside the phantom, 
the resulting input file was 22MB.
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The imcn subroutine in MCNPX could not handle an input file of such size. This 
problem was tackled by the author in the same manner of the MCNP4C2 input file. 
Since an organ has many repeating voxels in each direction, the IDL code converted 
the phantom into a list of universe numbers taking advantage of the MCNPX built-in 
{nR) feature for the fill card in the input file. The input file was thus reduced to 1.8MB 
only, which MCNPX is capable of handling. Coronal and axial views of the Zubal 
phantom with arms and legs using MCNPX plotting features is shown in Figure 2.7.
Cut level
Figure2.7: Axial at the kidneys level (left) and Coronal (right) views of the complete 
Zubal phantom as drawn by plotting features of MCNPX. On the right some IDs 
number (universes) can be seen on the axial view.
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2.4 Assigning physical properties to the Zubal phantoms
In order for an anatomical model to be studied using a Monte Caiio code, the various 
organs or tissues of interest have to be ‘named’ with their corresponding physical 
properties, (i.e. their tissue composition and density). This allows the simulation of 
radiation transport in each voxel in the model to be linlced to the interaction cross- 
section libraries in a Monte Carlo code. Given that the neutron cross-section data are 
documented on isotopes bases, the isotopic composition of each organ need to be 
specified. Internal organs are considered to be homogeneous in density and 
composition. Different densities and compositions are used for the lungs, skeleton 
(bone), soft tissue, and air surToimding the phantom, (as shown in the images in 
Figure 2.8), for Zubal head-torso part which has been plotted using the plotting 
features of MCNP. Tissue compositions that have been used for the head-torso Zubal 
phantom in this study consist of those recommended for the ‘Reference Man’ in the 
ICRP23 Publication {ICRP, 1975). A  comparison between the organ masses in the 
Reference Man {ICRP, 1975), the Zubal model {Zubal et al, 1994a, 1994b), MIRD 
{Cristy and Eckerman, 1987), and VIPMAN {Xu et a l, 2000) is presented in Table 
2.3. The last column shows the percentage deviation of the Zubal model organ masses 
relative to the ICRP data for the Reference Man.
The description of the different tissue compositions is restricted to 11 vital elements: 
H, C, N, O, Na, Mg, P, S, Cl, K, and Ca, whilst for air sun'ounding the phantom the 
elements C, O, N, and Ar are used. The coiresponding concentmtions have been taken 
fi'om ICRP23 {ICRP, 1975). Other elements, less than 0.005% by weight collectively 
{Nabelssi and Hertel 1993a), were neglected in this study. The exact compositions of 
the four materials (three types of tissues + air) ar e shown in Table 2,4. The densities 
for the lungs, bone, and soft tissue were taken from values proposed by Nabelssi and 
Hertel (1993a), and are equal to 0.2958, 1.4862, and 0.9869 g cm~ ,^ respectively. The 
composition and density for soft tissue has been averaged fr om the data for brain, 
colon, heart, kidneys, liver, pancreas, spleen, testes, and thyroid.
As the name of the method implies (‘Monte Carlo’: conceptual roulette wheel game), 
a selection of a random nuclear process is made, where the computer generates a 
random number between 0 and 1. Thus, the computer compares the probability (cross- 
section) of occurxence for each interaction and determines the type of interaction that 
will eventually take place.
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Figure 2.8 Two transverse slices through the Zubal voxel-based phantom (A) at the 
height of the throrax and (B) at the height of the mid thigh and testes, drawn using the 
plotting features of MCNP. Four different materials can be distinguished: soft tissue 
(violet), bone (dark green), lung (dark blue), and air surrounding the phantom 
(yellow). Voxels constructing the whole anatomical model are also clearly observable.
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Table 2.3. Organ and tissue masses in the ICRP 23 Reference Man, the Zubal model, 
MIRD, and VIPMAN.
Density
(g cm~^)
Mass (g) Zubal-
Organ JRef.
Man
Zubal MIRD VIPMAN R e f /
Adrenals 1.02 14 3 16.3 8.0 -78.6
Bladder wall 1.02 50 154.2 47.6 40.5 +208.4
Brain 1.04 1,450 1,491 1,420.0 1,247.4 +2.8
Colon 1.04 670 895.7 762.0 994.3 +33.7
Heart wall 1.03 330 N/A 316.0 401.8 —
Eye lens 1.10 15 15.8 — 1.1 +5.3
Kidneys 1.05 310 373.2 299.0 33&0 +20.4
Liver 1.05 L800 1,434 1,910.0 1,935.5 -20.3
Lung 0.26 1,200 756.5 1,000.0 910.4 -37.0
Muscle, skeletal 1.04 29,000 36,070 - 42,963.9 +24.4
Oesophagus 1.04 40 31.5 - 39.9 -21.3
Pancreas 1.05 140 3&8 94.3 8Z8 -7 2 3
Prostate 1.05 16 N/A - 19.5 -
Red bone marrow 0,98 1,170 570.9 1,118.4 -51.2
Small intestine 1.04 1,000 1,296 1,100.0 1,236.2 +29.6
Skin 1.10 3,300 6,676 3,010.0 2,296.2 +102.3
Spleen 1.06 150 272.8 183.0 239.9 +81.9
Stomach 1.04 400 251.5 158.0 154.9 -37.1
Testis 1.04 35 72.5 39.1 21.4 +107.1
Thymus 1.03 25 N/A 20.9 11.5 -
Thyroid 1.05 20 5.1 20.7 27.5 -74.5
Whole body (g)
73,000 81,728 73,224.8 103,202.3 +12.0
Height (cm) 176 175.3 170 186 -0.4
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The process is repeated for a large number of incident particles, where each of the 
particles deposits all its energy or escapes from the model. Accuracy and reliability of 
this method is based on the fact that, by repeating the process using large numbers of 
particles, it is possible to predict the physical processes that could be observed 
experimentally and the distribution of the dose absorbed in each of the organs in the 
model (Xu et al, 2000).
Table 2.4. Elemental compositions 
fr actions in g  cm ~ \  and air (atomic 
1993a].
for the lungs, bone, and soft tissue (weight 
fractions in atoms cm~^) [ (Nabelssi and Hertel,
Element Z
Lungs
(g cm'^)
Bone
(g cm~^)
Soft tissue Air
(atoms cm~ )^
H 1 0.10134 0.07337 0.10454 —
C 6 0.10238 0.25475 0.22663 0.000124
N 7 0.02866 0.03057 0.02490 0.755267
O 8 0.75752 0.47893 0.63525 0.231781
Na 11 0.00184 0.00326 0.00112 —
Mg 12 — 0.00112 — —-
P 15 — 0.05095 0.00134 —
S 16 0.00225 0.00173 0.00204 —
Cl 17 0.00266 0.00143 0.00133 —
A r 18 — — — 0.012827
K 19 0.00194 0.00153 0.00208 —
Ca 20 — 0.10190 — —
The whole simulation is completed in two stages. In the first stage, the input file is 
read by the code to extract any useful information about the geometry of the problem 
(cells, materials, tallies, cross-sections, etc.). The time that the code spends on this 
stage strongly depends on the number of voxels in the irradiated model. 
Consequently, organ shape and volume (see Figure 2.9) are two factors that mainly 
influence the simulation of radiation tr'ansport (Yoriyaz et al, 2000). For example, for 
the 4-mm voxel resolution that has been chosen in this study (thus, the total number of
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voxels is 236x73x128 = 2,205,184), a Pentium-4 2.2 GHz processor with 512 MB of 
RAM spends about 45 minutes in the first stage, while the size of each input file can 
be as large as 0.9 MB. For the original 1x1x10 mm voxel size (torso), the Zubal 
model contains almost 141.2 million voxels, whose geometry, location, and material 
composition needs to be individually read by the code. For this high-resolution model, 
the input file would be as large as hundreds of MB, which would require an extensive 
amount of system memory and a very long simulation time. The second stage includes 
the transport of particles in the geometry read in the previous stage. For the voxel 
resolution used in this study, typical numbers of particles transported in 800 minutes 
vary between about 50 million for higher energies (>1 MeV), and about 150 million 
for thermal neutron energies.
Kidneys
Liver
(a)
Kidneys
Liver
Figure 2.9. Anatomical shape comparison of the liver and kidneys between (a) the 
Zubal realistic phantom (voxelised anatomy), and (b) the MIRD mathematical model 
[From Yoriyaz et al. (2000)].
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The complete Zubal Model ( with aims and legs) was adopted in MCNPX code which 
offers an advmtage of specifying more material types to the tissues identified on the 
model. A comparison of the organ masses with ICRP Publication 89 and VIPMAN 
values are provided in Table 2.5.
Table2.5. Comparison of the mass of selected organs fi*om the Zubal with arms and 
legs model with the ICRP 89 and the VIP-Man values
Organ
Zubal 
complete 
model (g)
ICRP 89(g) VIP-Man (g)
Designated Organs:
testes 725 35 (107%) 21.4 (239%)
red bone marrow 864.2 1170 (-26%) 1118.4 (-23%)
colon 895.7 670 (34%) 994.3 (-10%)
lungs 756.5 500 (51%) 910.4 (-17%)
stomach 251.5 400 (-37%) 154.9 (62%)
bladder 154.2 50 (208%) 40.5 (281%)
liver 1434.2 1800 (-20%) 1935.5 (-26%)
oesophagus 31.5 40 (-21%) 39.9 (-21%)
thyroid 5.1 20 (-74%) 27.5 (-81%)
skin 6676.3 3300 (1()294) 2296.2 (191%)
bone surface 12482.2 10500 (19%) 9227.8 (35%)
Remainders:
adrenals 3.0 14 (-78%) 8 (-62%)
brain 1762.3 1450 (22%) 1247.4 (41%)
small intestine 1295.6 1000 (30%) 1236.2 (5%)
kidney 373.2 310 (20%) 338 (10%)
muscle 36067.0 29000 (24%) 42963.9 (-16%)
pancreas 3&8 140 (-72%) 82.8 (-53%)
spleen 272.8 150 (82%) 239.9 (14%)
Whole Body 81742.1 73000 (12%) 103202.3 (-21%)
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The tissue compositions and densities were taken from ICRU Report 44 and are 
shown in Table 2.6. Figure 2.10 shows a coronal view of the complete Zubal 
phantom using the MCNPX plotting feature with nine types of materials plus air 
surrounding the phantom.
Muscle
Lung
Soft tissue
Adipose
#
Hf
. 1
Skin
Red bone 
marrow
Yellow bone 
marrow
Figure 2.10: Coronal view of Zubal complete model using MCNP plotting features. 
Different material can be noted; light blue (bone), brown (skin), yellow (muscle), 
navy (soft tissue), blue (lung), red (adipose), green (red bone maiTow) and light gi'een 
for yellow bone man'ow.( note: cartilage is not shown in this view )
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Chapter 3
Dose calculations
3.1 Dose Calculation Procedure
hi this chapter, the dose calculation procedui'e will be explained along with source 
arrangements used in this study. MCNP4C2 was used with the head-torso Zubal 
phantom and the MCNPX code used with complete Zubal phantom with aims and 
legs. The same method was applied to calculate the dose for both phantoms studies 
and for both codes. However, the absorbed dose and effective dose comparison with 
other models will be regarded for the complete phantom only and the head-torso 
simulation of neutron radiation transport will be used for other dose analyses i.e. 
photon fractional contiibution to neutron absorbed dose and Maxwell fission 
spectrum exposure along with effective dose calculation and conversion coefficient 
for the Zubal head-torso model. MCNPX offers more options and faster special 
heating tally for dose calculation fiom primary and secondary particles and therefore 
used for the complete model absorbed dose, effective dose and conversion 
coefficient calculations.
A summary of the dose calculations performed in this work is provided in Table 3.1. 
Table 3.1 Summary of the dose calculations studies in this work.
Monte Carlo code Phantom Studies carried out
• Neutron Fluence to dose conversion
coefficient
• Effective dose from neutron external
exposure
• Photon contribution to total effective
MCNP4C2 Zubal (head + torso ) dose
« Absorbed dose from Maxwell fission
spectmm
e Photon contribution to absorbed dose
from Maxwell fission spectrum
* Neutron Fluence to dose conversion
coefficient
• Effective dose from neutron external
MCNPX Zubal with added amis and legs exposure
e Comparison with VIPMAN & MIRD
• Comparison of Conversion coefficients at
measured points
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3.2 Source exposure configurations
The phantom is placed in air and is iiTadiated under three different source 
configurations defined in the ICRP/ICRU-related reports {ICRP, 1996; ICRU, 1998): 
anterior-posterior (AP), posterior-anterior (PA), and lateral (LAT), talcen from the 
left side in this study. For each of those source geometries, the phantom is iiTadiated 
with 12 monoenergetic, monodirectional neuti'on beams, originating fi*om a very thin 
non self-absorbing surface source. The source is parallel to xz and yz planes of the 
phantom array for AP/PA and LAT orientations, respectively, and has a uniform 
intensity distribution between its edges. MCNP was run in n-p-e mode, i.e. source 
neutrons with photon and electron generation as can be seen in appendix C which 
contain the MCNP input file source card. A comparison will be provided in the result 
section for the effect of the surrounding medium as well the effect of proton 
transport on the absorbed dose for selected organs. The neutron beam energies range 
fi'om thennal (10“  ^ eV) to 10 MeV with increments of one order of magnitude, plus 
another transport at 5 MeV and an extra neutron beam energy of 20 MeV was 
ti'ansported for the Zubal complete model to be consistent with other models 
comparisons. For each neutron energy, different number of particles was required in 
order for the output results to be ‘generally reliable’ (relative statistical error <5%).
3.3 Absorbed dose calculation
The energy deposited in every organ of the model due to interactions of the primary 
paificles only (incident neutrons), was determined using the *F6 tally of the MCNP, 
and the result is reported for each organ in units of Jerlis g~^  (1 Jerk -1 0 ^  Joules) 
along with the associated relative statistical eiTor. Therefore, by multiplying those 
values by a factor of 10^ ,^ the results are finally converted to absorbed dose in units 
o f Joules kg~  ^ {1J  kg  ^ = 1 Gy).
More specifically, the F6 heating and energy deposition tally is the following track 
length estimate:
^  f  I  I T  (3.1)
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where pa is the atom density {atoms barn^ c r n \  pg is the gi*am density (g cm~^), and 
H(E) is the heating response (summed over all nuclides in a material). The units of 
the heating tally ai'e M eV g~\ The asterisk (*F6 on MCNP input file) changes the 
luiits to Jerlcs g~  ^ (1 MeV  = 1 . 6 0 2 1 9 x 1 JerJcs) {Briesmeister, 2000).
The F6 tally deposits the photons elsewhere, so it does not include gamma heating, 
which is particularly significant at lower neutron energies. The true heating is found 
by summing the neuti*on and photon F6 tallies in a coupled neutron/photon 
calculation {Briesmeister, 2000). hi a neutron-only problem, F6 will give the right 
heating of light materials only if  all photons escape the geometiy, which is not true 
for the irradiation conditions and the model used in this study. Therefore, another 
way for the energy deposition fi.*om both photons and electrons should be found, as 
these are the main secondary particles produced by neutron interactions in the 
phantom at lower energies (<~100 keV).
The alternative method used was to compute energy deposition due to secondary 
photons and electrons using the *F8 tally, which is a surface estimator rather than a 
track length estimator. The F8 tally provides the energy distribution of pulses created 
in a detector by radiation and is called a pulse height tally. Both photons and 
electrons will be tallied if  present, even if  only electrons or only photons are on the 
F8 card. An asterisk on the F8 card converts the tally fi.*om a pulse height tally to an 
energy deposition tally, the result of which is expressed in units of MeV. By 
multiplying the output values by a factor of 1.60219xl0~^^ J M e V \  and dividing the 
obtained result with the organ mass in kg, the results aie finally converted to 
absorbed dose in units o f  Jkg~^ (Gy)-
Having separately calculated the absorbed dose from neutrons, and photons/ 
electi'ons, the total average absorbed dose in a specific organ is found by summing 
up the modified outputs of both the F6 and F8 tallies. Calculations were then 
noimalised to the unit of incident neutron fluence (pai'ticle/cnT^) to express the 
results in the form of fluence-to-absorbed dose conversion coefficients. For the 
calculation of the incident fluence in every cell/organ, the F4 tally (track length 
estimate of cell) was used. The definition of particle flux is
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= (L2)
where v is the particle velocity, and N  is the particle density = particle weight (W) 
per unit volume. Roughly speaking, the time integrated flux is
(3.3)
If ds=^v dt is the elementary track length, then the time-integrated flux is
I  L  f  lN (7 ,E ,t)  ds d E ^  (3.4)
Because N (r,E ,t) ds is a track length density, MCNP estimates this integial by 
summing W Ti /V  for all particle tracks in the cell, time range and energy range. 
Because of the track length term Ti in the numerator, this tally is Imown as a track 
length estimate of the flux. When the source has the units of particles, this tally 
represents a fluence tally {Briesmeister, 2000).
Figure 3.1 illustrated the AP/PA and LAT sources and F4tallies (normalised 
incident neutron plain) plotted using IDL. As all interaction data are below 20 MeV, 
the table-based data of the Evaluated Nuclear Data File B VI (ENDF/B VI) cross 
section libraries were used. The S(a,p) scattering law for light water at 300 K was 
used for all materials composing die phantom, in order to model the molecular 
scattering of theimal neutions at body temperatures {Briesmeister, 2000). Thermal 
S(a,P) tables are not required, but they ai’e absolutely essential to get correct answers 
in problems involving neutron thermalisation. The S(a,p) theimal scattering 
treatment is a complete representation of thermal neutron scattering by molecules 
and crystalline solids. The two processes allowed are inelastic and elastic scattering 
with no change in the outgoing neutron energy for solids, and with an energy range 
from an upper limit of typically 4 eV down to 10“  ^eV.
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Figure 3.1: Zubal complete phantom is irradiated from the neutron sources AP 
(blue), PA (yellow) and LAT (green) straight lines. The normalised plane (tallies 
using F4) dashed lines).
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3.4 Effective dose calculations
In the calculation of the effective dose ( Zubal head-torso model ) , the dose in the 
testes represents the dose given to the gonads, as the Zubal phantom is a male model, 
and therefore, no ovaries are considered. Seventeen organs of those studied in this 
work have a contribution to the total effective dose as recommended by ICRP60 
(1991), whilst only one of the eyes is considered to account in the effective dose. 
From the organs with large tissue weighting factors, red bone marrow (wt=0.12), 
breast (0.05), and bone surface (0.01), have not been taken into consideration. The 
bone surface, peiiostemii, is 10pm thick of connective tissue and bone-forming cells 
called osteoblasts. With this level o f resolution it is difficult to segment it from the 
original image data. These tissues were not identified on the original phantom (Zubal 
head-torso model). Therefore, because of this omission, the sum of the weighting 
factors is 0.825; hence, the final results for the effective dose are given after 
normalisation of the sum of W j’s  to unity. In the calculation of the ‘remainder’ dose, 
eight organs were talcen into account: adienals, brain, ti’achea, kidney, skeletal 
muscle, pancreas, small intestine, and spleen. The utems has been omitted, and the 
thymus has not been segmented in the anatomical model used. The remainder data 
have been calculated by averaging the organ and tissue doses with equal weighting, 
as applied by all authors mentioned in Table 1.1. The ICRP’s ‘splitting rule’, known 
as ‘footnote 3’ (JCRP, 1991), where the remainder organ receiving the highest dose 
is assigned with a weighting factor Wt = 0.025, and the remaining 0.025 is equally 
shared among the other remainder organs, has not been applied.
Aside from the factors that have been mentioned in the last paragraph, the studies 
were carried out for the Zubal complete model (with added arms and legs) following 
the ICRP Publication 74 suggestion to use the dose to the bone as a conservative 
estimate of the dose to the bone surface. Also, ICRP Publication 69 recommended 
the incorporation of the upper large intestine into the definition of colon (instead of 
being one of the remainder organs) and this new convention was followed. Although 
bone marrow was identified in the phantom, red and yellow bone manows were not 
differentiated from each other, hi adults, the red bone marrow resides primarily in 
the skull, sternum, ribs, vertebrae, pelvis and the head of the femora and humeri. The 
portion of bone man'ow identified in these bones was re-labelled as red bone marrow 
and the rest as yellow bone marrow using IDL as an interface between the original
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phantom data and the MCNP input files. A significant portion of bone marrow was 
not segmented in the original phantom, as illustrated in Figure 3.2. The mass of red 
bone marrow in the phantom is only 864.17g, which is 26% less than the figure 
given in ICRP Publication 89.
Figure 3.2: 3D representation of the bone (left) and the re-labelled red bone marrow 
the dark shaded areas and the yellow bone marrow the brighter areas on the phantom 
(right). Significant portion of the bone marrow was not segmented in the original 
phantom e.g. on the skull, shoulder, ribcage etc.
3.5 Conversion coefficients at measured points
As indicated earlier (chapter 1 section 1.3) the conversion coefficient is calculated by 
dividing the absorbed doses over the fluence on the incident plane of the phantom. In 
this study, an attempt has been made to calculate the conversion coefficient by 
choosing two normalisation points on the phantom. The choice of their locations 
have been made according to normal site where in practice a radiation personal
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dosimeter is placed i.e. near the heart wall and near the bladder as illustrated in 
Figure 3.3 .
r
i  f
Figure 3.3: The location of the normalised fluence points illustrated on axial views 
(left top) near the heart (left bottom) near the bladder drawn by MCNPX plotting 
feature and the corresponding position on the phantom drawn using DDL (right).
In order to calculate the fluence at these particular points the exact location has to be 
worked out on a voxel by voxel basis using MCNPX plotting feature and knowing 
the dimensions of the phantom. The F4 tally was used with SD card which specify
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the volume of the universe when using repeated structure and lattice geometries 
{Briesmeister, 2000). The SD card value will be the volume of the union of the cells 
in this case (see input file appendix D). These calculations will be compared to the 
overall incident plan (see figure 3.1) to evaluate the changes in organs absorbed 
doses and effective dose.
3.6 Monte Carlo calculation precision
3.6.1 Monte Carlo means, variances, and standard deviations
A very large number of histories ai*e sampled during the com'se of the problem, and 
the Monte Carlo results represent an average of the contributions from all histories. 
The statistical error or uncertainty associated with the result, which is printed in the 
output as a second number after the result, can be considered as having equal 
significance as the answer (tally) itself. This error not only provides insight into the 
quality o f the result, but can also determine if a tally appears statistically well 
behaved. A badly behaved tally results in an en'or that generally does not reflect the 
tme confidence interval of tlie result and, therefore, the answer could be completely 
erroneous {Briesmeister, 2000).
An answer (tally) is obtained by ‘sampling possible random walks and assigning a 
score X/, to each random walk’. For instance, x/ could be the energy deposited by the 
z* random walk, when the F6 tally is used. The true mean is estimated by the sample 
mean:
—  \ .Æ^ = (3.5)
where x, is the value of x for the f" history, and N  is the number of histories 
calculated in the problem.
The variance, a, of the population of x values is a measure of the spread in these 
values, and can be estimated by the Monte Carlo code as S, given for large A  by
1 ' A  . -  2 “ 7  - 2 ^ (3.6)
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and
(3.7)
The quantity S  is the estimated standard deviation of the population of x based on the 
values of x, that were actually sampled. The estimated variance of x is given by
S - = —  (3.8)'  N
It is important to emphasise that S- is proportional to 1/ V #  , which is the inherent 
di'awback to the Monte Carlo method (Briesmeister, 2000).
3.6.2 Precision and accuracy
Precision is determined as the uncertainty in x caused by the statistical fluctuations 
of the Xi ’s sampled by the Monte Carlo process, as illustrated in Figure 3.3. 
Accuracy is a measure of how close the expected value ofx,  E(x), is to the tme 
physical quantity being estimated. The difference between this tme value and E(x) is 
called the systematic eiTor, which is seldom known. En’or or uncertainty estimates 
for the results of Monte Carlo calculations refer only to the precision of the result 
and not to the accuracy.
3.6.3 Estimated relative errors in MCNP
The estimated relative error appears as a niunber following the tally in the output 
file, and is defined as
6"-j%== (3.9)
X
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The relative en'or is a convenient number because it represents statistical precision as 
a fractional result with respect to the estimated mean. Therefore, in order to calculate 
the statistical error, the estimated relative error provided must be multiplied by the 
estimated mean itself, which is also provided in the output.
SYSTEMATIC ERROR
TRUTH E (x)
Figure 3.3. Discretion between precision and accuracy in the result of a Monte Carlo 
process [Redrawn from Briesmeister (2000)\
There are thi*ee such estimated relative errors provided in the output file for the 
calculation of the total mean absorbed dose for each organ of interest, thus one for 
each of the used tallies F6, F8, and F4. If Sf6, Sfs, and Sf4 are the statistical errors 
corresponding to the tallies F6, F8, and F4, respectively, and m is the mass of the 
organ of interest, then the total propagated statistical eiTor in the estimation of the 
total mean absorbed dose nonnalised per unit incident neutron fluence (see Figure 
3.1) inpGy cm ^  for this organ, is given by:
= ^ I S ( F 6 / F 4 f + S ( F S / F 4 f (3.10)
where
6'(F'6/F'4) = 1012 F4 + •F 4 (3 11)
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and
1.6x10“'" I 1 F8"S( F 8 / F4) =  s l , + ^ S l ,  (3.12)
The total propagated statistical error can then be expressed as a fraction in percent of 
the total mean absorbed dose via the formula
S y X D I ^ X ,  = xlOO (3.13)
where (D/0„),^, is the total mean absorbed dose normalised per unit incident 
neutron fluence.
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Chapter 4
Result aud Discussion 
4. A. Zubal head-torso model
4.1. A. Organ absorbed dose calculation
The calculated fluence-to-absorbed dose conversion coefficients in units of pGy cm^ 
are listed in Tables 1-18 (appendix E) for the 18 organs highlighted in Table 2.1 
(Chapter 2). Although the eyes ai'e not taken into account for the calculation of the 
effective dose, the absorbed dose results are still listed.
The propagated statistical uncertainties of the results, U, derived as explained in the 
previous chapter, are also noted as a fraction of the calculated value (in percent) and, 
in most cases, are lower than 5%. It should be mentioned that these uncertainties are 
based on the transport of approximately 50-150 million paificles for the studied 
irradiation geometries, depending on the energy of the particles and the specific 
geometiy. Smaller uncertainties could be achieved by transporting more particle 
histories or utilising any variance reduction technique provided by the code. 
However, due to the extremely time-consuming nature of the problem, the reported 
uncertainties are considered as satisfactory, since the relative en'or R given by 
MCNP is below 0.1 (in all cases), and is considered generally reliable and 
acceptable. Organs with relatively small tally volumes (eyes, adrenals, and thyroid) 
are presented with lai'ger uncertainties compared to those of voluminous organs, as 
the energy is reduced down to thermal levels. This is due to the fact that lower 
energy particles do not penetrate very deeply into the body, and therefore, fewer 
particles enter (lower incident neutron fluence) and fewer collisions occur in small- 
volume organs. The uncertainty for large-volume organs range between 0.05 and 
5.26%. For the eyes, adrenals, and thyroid, the imcertainty range from 0.67 to 9.13%, 
from 1.21 to 11.41%, and from 0.87 to 8.83%, respectively, for the particle energy 
range used. The organ that exhibits the wider range in uncertainty is the adrenals, as 
shown above, while the skin and skeletal muscle exhibit the narrower range in 
imcertainty with values that vary between 0.05 and 0.17%. The uncertainties values
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much depends on how much each organs exposed to the neuti'ons produced hy the 
source, which explained the variations in uncertainty values mentioned above. 
Figures 4.1-4.3 show absorbed doses for the organs studied, normalised per unit 
incident neuti'on fluence, as a function of particle energy. For comparison purposes, 
the absorbed doses for each organ and for all in'adiation geometries studied (AP, PA, 
and LAT) are plotted in the same graph. For clarity, the en'ors listed in (appendix E 
Tables 1-18) are not plotted in the graphs. Spline fit to the calculated values of 
absorbed dose for AP geometry is represented by a solid line, whilst the best fit to 
the absorbed dose data for PA and LAT geometries ai'e given with dashed and dotted 
lines, respectively. An absorbed dose curve could be roughly divided into three main 
parts. In the first part, the absorbed dose decreases rapidly as the energy is reduced 
from 10 MeV to about 100 keV, and then, in the second part, is maintained 
approximately constant until about 10“  ^ MeV, for all irradiation geometries. In the 
third part, (for energies below 10“  ^MeV (thermal)) , the absorbed dose drops again 
but not so rapidly as in the first part. In some cases, such as in trachea, Iddneys or 
oesophagus, a small increase in the absorbed dose is obseiwed below about 100 keV, 
which again starts decreasing at theimal energies. This small increase below 100 
keV results in the creation of a relatively shallow valley located at energies between 
100 keV-1 MeV. In most of the cases, iiTadiation of the body from the fi*ont (AP 
orientation) results in the largest absorbed doses, compared with the other iiTadiation 
geometries. On the other hand, lateral orientation is usually the one that contributes 
less to the absorbed dose, except for some special cases such as in brain, where LAT 
geometry mediation results in the highest dose. The PA orientation curve lies 
between the cui'ves for the other two orientations for the majority of the organs 
studied. This indicates that irradiation from the back of the body results in an 
absorbed dose which is lower than that resulting from iiTadiation from the front, and 
yet is higher than that resulted fr om LAT geometry. However, in the cases of the 
adrenals, kidneys, and spleen, irradiation fi'om the back results in the highest 
absorbed dose compared with the other geometries. Those organs are located at the 
back of the body, and hence, it is reasonable to receive higher doses when the body 
is irradiated from the back (PA), relative to other irradiation geometries. Similarly, 
organs such as the eye or rectum, receive the lowest doses when the irradiation 
occurs from the back of the body. This is because other organs/tissues lie in front,
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Figure 4.1. Skin, brain, skeletal muscle, eye, trachea, esophagus, lung and thyroid 
absorbed dose per unit neutron fluence.
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Figure 4.2. Liver, stomach, spleen, colon, pancreas, adrenals, kidney and bladder 
absorbed dose per unit neutron fluence.
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Figure 4.3. Rectum and testes absorbed dose per unit neutron fluence
The difference in the absorbed dose between the various geometries for a specific 
organ becomes larger as the energy increases from thermal to the higher energies. 
This is not clearly illustrated in the graphs presented in Figures 4 .1 ^ .3  because of 
the logarithmic scale used on both axes. However, this might not be true for the 
ratios of the absorbed doses resulted from the different geometries, which could most 
probably be larger at lower energies, and vice versa. For example, the absorbed dose 
ratios in case of esophagus for AP/PA is more by 38% and 6% for thermal energy 
and higher energy respectively while for the LAT/PA at thermal energy is 52% less 
and 5% more for higher energy. The same ratios of (AP/PA) for thyroid show a 
difference increase from 10% to 30% while for the (LAT/PA) ratios the difference 
decreases from 50% to 6% for thermal energy and higher energy respectively. 
Further analysis on this aspect it is not studied in the present work.
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4.2. A. Neutron and photon fractional contribution to absorbed dose
Incident neutrons undergo many interactions, mainly producing secondary photons 
during the slowing-down process, until they are fully absorbed or escape from the 
body. Neuti'ons and secondary-produced photons have different contributions to the 
absorbed dose in each organ, which are strongly energy-dependent. Absorbed dose at 
higher energies (>1 MeV) is primarily contiibuted from neutrons, with fractions that 
vary above 90%, but as the incident particle energy decreases, neutron contribution 
to absorbed dose drops dramatically to less than 5-10%. Analogously, photon 
contribution to absorbed dose in an organ for energies above 1 MeV can be 
considered as negligible (<5-10%). However, incident neutrons with energies of up 
to ~1 MeV produce secondary photons which deposit the major fr action of their 
energy, and hence the absorbed dose, deep in the body. Of special interest is the 
^H(n,y)^D reaction, which occurs with the participation of thermalised neutrons 
captured in hydrogen. This reaction is associated with the emission of 2.22-MeV 
photons, which due to Compton scattering, result in the production of secondary 
photons with energies of above about 1 MeV, depositing significant energy fraction 
in the body. Consequently 95-99% of the total absorbed dose at lower energies 
results from photon interactions into the body. Similarly, the absorbed dose 
contributed from neutrons at lower energies is essentially insignificant.
The graphs in Figure 4.4 illustrate the fractional percentage contribution (for the AP 
iiTadiation orientation) of neuti'ons and secondary-produced photons, respectively, to 
the absorbed dose, for seven selected organs/tissues investigated in this study (skin, 
lung, colon, stomach, kidney, testes, and pancreas). In this figure, the physical 
phenomena discussed in the previous paragraph can be clearly observed. For each 
individual organ, the sum of the neutron and photon contributions to absorbed dose 
is always 100%. Calculated dose fr'actions due to neutrons and photons for PA and 
LAT geometries have more or less similar behaviour to those plotted in Figure 3.7 
for AP geometry, and therefore, no additional data for the other geometries are 
provided.
It is worth noticing that the highest photon fr actional contribution to absorbed dose 
occurs in organs located deep in the body, such as the pancreas and kidneys, at all 
energies investigated. This can be considered as proof of the above discussion on the 
significant energy/dose deposition deep in the body, resulting from the
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Figure 4.4. Fractional contributions in percent of neutrons and secondary-produced 
photons, respectively, to absorbed dose, for seven selected organs/tissues 
investigated in this study (skin, lung, colon, stomach, kidney, testes, and pancreas), 
for the AP orientation. Note the log scale and the break between 10"  ^and 10“  ^MeV 
in the lower graph, where photon contribution to absorbed dose remains constant.
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secondary-produced photons with energies above 1 MeV. Indeed, the pancreas and 
kidneys are covered by large organs such as the liver, stomach, part of the rectum 
and colon, in the AP plane. Conversely, organs/tissues lying at the front of the body, 
such as the skin, testes, and lungs, receive the highest portion of their absorbed dose 
from neutrons at all of the energies studied, as illustrated in Figure 4.4. This is 
further studied in Figures 4.5-^.6, where the fractional contributions of both 
neutrons and secondary-produced photons for the testes and kidneys, are shown for 
the AP and PA irradiation geometries.
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Figure 4.5. Fractional contributions in percent of neutrons and secondary-produced 
photons to absorbed dose in testes, for the AP and PA irradiation geometries.
Testes (at the front of the body) receive the highest fraction of absorbed dose due to 
neutrons in the AP geometry, while the highest fraction of absorbed dose due to 
photons is received in the PA geometry, when the organ is irradiated from the back. 
In the case of the kidneys, which are located deep in the body, the opposite 
phenomenon occurs. The highest fraction of absorbed dose due to neutrons is
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delivered in the PA geometry, since the kidneys are close to the irradiated surface. 
The highest fraction of absorbed dose due to photons is received in the AP geometry, 
when the neutron beam traverses all of the organs at the front of the body.
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Figure 4.6. Fractional contributions in percent of neutrons and secondary-produced 
photons to absorbed dose in kidneys, for the AP and PA irradiation geometries.
4.3. A. Effective dose calculation
Table 4.1 provides the fluence-to-effective dose conversion coefficients, E/0, in 
units of pSv cm^, together with the relative error in percent after propagation from 
organ-absorbed doses. The effective dose conversion coefficients after normalisation 
of the tissue weighting factors to unity, (E/0)n, are also shown in a separate column 
for each orientation studied.
From the calculated effective dose values, it can be deduced that AP irradiation 
yields the largest effective dose at all the energies studied in this work, compared 
with the other two geometries. An explanation for this is that the secondary particles 
produced due to the interactions of incident neutrons in the body are characterised by 
low penetration, depositing most of their energy in the front organs. Those organs
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are the ones in which large weighting factors have been considered (e.g. gonads with 
W t=0.20), and therefore contribute more significantly to the effective dose. AP 
geometry effective dose values are followed by those for PA geometry, while LAT 
orientation always results in the lowest levels of effective dose. An exception occurs 
at the 0.1-1 MeV region, between the PA and LAT orientations, where LAT yields 
larger effective dose than the PA geometry.
A comparison between the effective dose contributions from each o f the organs that 
result in the total effective dose, indicates that this exception is due to organs with 
large weighting factors, e.g. testes and colon, which receive larger doses in the LAT 
geometry irradiation for this energy range. Thus, it can be concluded that the AP 
geometry supplies larger shielding to organs like the testes and colon for energies in 
the range of 0.1-1 MeV, rather than the LAT geometry does. The variability in the 
contributions of the organs that account to the determination o f the total effective 
dose is discussed later.
Table 4.1. Effective dose, E /0, and tissue-weighting-factor normalised effective 
dose per tmit fluence, (E/®)n (pSv cm^), and statistical uncertainty U (%) fi'om mono- 
energetic neutrons under various orientations.
Energy
(MeV)
AP PA LAT
E /0 (£/^)n U (% ) E /0 U (% ) E /0 U (% )
l.GxlQ-^ 2.5 3.1 13.3 1.7 2.0 57.7 1.0 1.2 58.9
1.0x10“® 2.9 3.5 11.0 1.8 2.2 49.7 1.2 1.5 53.3
1.0x10“^ 3.1 3.7 6.3 1.9 2.4 40.2 1.4 1.8 33.9
1.0x10“® 3.2 3.9 4.6 2.1 2.5 30.7 1.5 1.8 29.9
1.0x10“® 3.3 4.0 3.5 2.1 2.6 28.7 1.6 1.9 21.4
1.0x10“"^ 3.2 3.9 3.1 2.1 2.6 26.1 1.6 2.0 10.9
1.0x10“® 3.2 3.8 2.6 2.1 2.5 26.6 1.6 1.9 14.8
1 .0x l0“2 3.8 4.6 2.7 2.1 2.7 30.7 1,7 2.0 15.7
1 .0x l0“i 13.1 15.9 2.0 4.0 4.8 24.4 4.7 5.7 10.3
1.0x10* 80.0 97.6 0.4 42.3 51.6 1.8 43.5 53.1 0.9
0.5x10^ 181.2 221.0 0.3 157.2 191.7 0.6 117.8 143.6 0.3
1.0x10^ 214.8 262.0 0.2 193.7 236.5 0.2 168.8 205.9 0.3
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Figure 4,7 shows the calculated fluence-to-effective dose conversion coefficients, 
E/0, as well as the normalised fluence-to-effective dose conversion coefficients 
(E/0)n, as a function of energy, for the various geometries investigated.
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Figure 4.7. Fluence-to-effective dose conversion coefficients, E/0, and normalised 
fluence-to-effective dose conversion coefficients (E/0)n, as a function of energy, for 
the various geometries investigated.
Figure 4.8 illustrates the effective dose ratios of the possible combinations between 
the various orientations; thus AP/PA, AP/LAT, and PA/LAT. For energies up to 10 
keV, the AP/PA, AP/LAT, and PA/LAT effective dose ratios are relatively constant, 
with values of about 2.2, 1.6, and 1.3, respectively. There is a tendency for the 
effective dose to increase at thermal energies for the AP/LAT and PA/LAT ratios. At 
the energy range between 1 keV-100 keV, a rapid increase in the AP/PA and 
AP/LAT ratios is observed as the energy increases. This is most likely due to the 
significant contribution made to the effective dose from organs with large weighting 
factors that are located in the front of the body. As the energy further increases from 
100 keV to 10 MeV, the ratios drop again to levels that are even lower than those for
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energies below 1 keV. On the other hand, a shallow ‘valley’ is observed in the 
PA/LAT ratio in the energy range of 1 keV-10 MeV. The ratio in this case drops 
even lower than unity, indicating that LAT-contributed effective dose is larger than 
that from the PA geometry in this energy range, for reasons that have already been 
discussed above.
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Figure 4.8. Effective dose ratios between the various orientations studied, i.e. 
AP/PA, AP/LAT, and PA/LA
A comparison between the effective dose contributions {in percent) to the organs that 
account to the determination of the total effective dose in this work for the AP 
orientation is presented in Figure 4.9. Seventeen organs of those studied in this work 
have a contribution to the total effective dose as recommended by ICRP60 (1991)^ 
while the eyes are not considered to account in the effective dose. Red bone marrow, 
breast, bone surface, thymus, and uterus have not been taken into consideration
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large number of curves plotted in the same graph, different 
numbers have been applied to each curve for better 
comprehension between the various organ contributions. 
Depending on their contribution to total effective dose, the 
various organs can be grouped into two broad categories: 
those that contribute with a fraction less than 3%, and those 
that have a fraction above this limit which extends up to 
50%. The first category consists of nine organs: all of the 
eight organs considered as the ‘remainder’ in this study plus 
the skin.
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Figure 4.9. Comparison between the fractional contributions in percent of the organs 
that account to the determination of the total effective dose for AP orientation.
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Organs that are chai'acterised by large weighting factors (0.05, 0,12 or 0.20) belong 
to the second category. For energies up to 1 keV, the relative contribution to total 
effective dose remains approximately constant for all organs studied. Above this 
energy value, the contribution of some organs increases with increasing energy, 
notably the testes, trachea, brain, and skin. Other organs contribute to the total 
effective dose with the lowest haction presented in the energy range investigated, so 
forming a fraction ‘valley’ between the energies of 1 keV and 10 MeV (e.g. spleen, 
kidney, adrenals, liver, bladder, etc.). The latter are, in general, the organs that are 
located relatively deeply in the body.
The dependence of received dose on the organ location and iiTadiation geometiy has 
been discussed earlier in this chapter. Nevertheless, at an energy of 500 keV, the 
dose to the testes results in over 50% of the contribution to the total effective dose. 
This is in comparison with the contribution from the stomach, lung, thyroid, and 
colon of approximately 10% each. The testes are the organ that always contributes 
the largest fraction to the total effective dose, followed by the stomach, except for 
energies above 5 MeV, where the lungs and colon contribute with larger fractions to 
the total effective dose. The brain is the organ that contributes with the lowest 
fraction to the total effective dose (0.1%), except for energies above about 50 keV, 
where adrenals, kidneys, spleen, pancreas, and rectum exhibit the lowest contribution 
to the total effective dose with a fr action of less than 0.5% each.
For comparison purposes. Figures 4.10-4.11 show the fr actional contribution in 
percent of each organ studied to the total effective dose for PA and LAT 
orientations, respectively, without any fuiHier discussion on the same subject
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4.4. A. Absorbed dose from a Maxwell fission spectrum source
The incident neutron energy is the primary factor that determines energy 
deposition/dose absorption in an irradiated body. Many authors have performed 
calculations of fluence-to-dose conversion coefficients for irradiation by incident 
monoenergetic neutrons, as has been carried out in this study. In fact, neutron fields 
around medical linear accelerators are rarely monoenergetic extending over a wide 
energy range (thermal-tens o f MeV) (IAEA, 1988; Cossairt and Elwyn, 1987). If 
such fields are to be evaluated, appropriate averaging of those coefficients should be 
performed. An attempt has been made to calculate the absorbed dose in various body 
organs in the form of fluence-to dose conversion coefficients, using an MCNP built- 
in analytic function to generate a continuous probability density function for the 
source variable. The function used represents a Maxwell fission energy spectrum
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Figure 4.12. The Maxwell fission spectrum probability p(E) as a function of energy 
with effective temperature a = 1.2895 MeV.
and gives a source probability p(E) of the form
p{E) = c VÊ e Ela (3.1)
where a is the effective temperature in MeV (default value: 1.2895 MeV). Figure 
4.12 shows the Maxwell fission spectrum probability p(E) as a function of energy.
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Certainly, this spectmm does not represent the neutron source energy distribution in 
an accelerator environment, but it is considered to be closer to reality. The results of 
the absorbed dose normalised per unit incident neutron fluence in 18 organs after the 
transport of about 60 million particles in the AP, PA, and LAT source configurations 
are presented in Table 4.2, along with the related statistical uncertainty, U (%), for 
each case. Calculated results of absorbed dose normalised per unit incident neuti'on 
fluence for the three source configurations studied are graphically shown in Figure 
4.13.
Table 4.2. Absorbed dose per unit fluence Dt/O ipGy cm^), and statistical 
uncertainty U (%) from the Maxwell fission spectrum source under AP, PA, and 
LAT orientations.
AP PA LAT
Tissue/Organ Dt/ ^ f / w D x/^ Dx ®
Sldn 12.6 0.05 12.2 0.08 13.6 0.06
Brain 9.1 0 J3 9.1 0.48 9.1 0.23
Muscle 8.7 0.06 8.3 0.10 8.8 0.07
Eye 13.9 0.78 10.2 3^9 12.9 (194
Trachea 7.5 0.54 5.9 1.21 6.5 0.83
Oesophagus 5.8 0.72 5.2 1.18 6.2 &89
Thyroid 8.5 1.08 5.8 3.01 5.7 2.63
Lung 6.3 0.18 6.0 0.27 6.1 0.20
Liver 6.4 0.22 6.5 0.42 6.6 0.18
Stomach 6.0 0.42 6.0 0.91 6.8 0.73
Spleen 6.5 0.53 6.7 0.61 7.8 0.94
Colon 6.7 0.19 6.6 0.45 6.3 0.24
Pancreas 5.8 0.91 5.8 1.62 6.4 1.24
Adrenals 6.1 2.73 5.7 3.44 6.0 2.53
Kidneys 6.3 0.47 6.1 0.44 6.2 038
Bladder 6.5 0.35 6.5 0.91 6.6 0.63
Rectum 6.1 0.88 6.2 0.86 6.1 1.02
Testes 14.2 0.40 12.9 1.66 14.0 0.79
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Figure 4.13. Comparison of absorbed dose per unit fluence in each organ studied 
from the Maxwell fission spectrum source under AP, PA, and LAT orientations.
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In most of the organs, absorbed dose calculated for all source geometries are within 
the range of 5-8 pGy cm^. Each of the AP and LAT orientations result in the largest 
absorbed dose values compared with other geometiies in eight organs/tissues. Only 
in the case of the rectum, does the PA orientation result in the highest absorbed dose 
relatively to other geometiies. However, this is not very reliable because of the 
relatively large associated uncertainty. Thiee organs -  the testes, skin, and eye -  
produce absorbed dose results that are above 12 pGy cm^. Eye and testes receive the 
highest dose when they are irradiated from the front (AP), while the skin receives its 
highest dose when inadiated from the back (PA). Uncertainty generally lies in levels 
below 1.5%, although organs with small tally volumes exhibit uncertainties up to 
3.6%. More specifically, the eye, thyroid, and adrenals are the organs with the higher 
levels of uncertainty, which in the AP orientation, extend up to 3.59, 3.01, and 
3.44%, respectively. However, these uncertainties are comparable with those 
calculated for monoenergetic neutron beams in the same energy region (about 1 
MeV).
Figure 4.14 shows the relative fr actional contribution in percent of neutrons and 
induced photons, respectively, to the absorbed dose, for the organs/tissues 
investigated in this study for the AP irradiation orientation. Neutron contribution to 
dose varies within the range of 63-97% for all organs studied, while photon 
contribution varies con’espondingly between 3-37%. The largest fraction of 
absorbed dose due to neutrons is contributed in organs such as the testes, lungs, 
thyroid, eye, and brain, while the lowest fraction is observed in organs located 
deeply in the body such as the kidneys, rectmn, adrenals, and pancreas. The relative 
neutron contribution to absorbed dose in each organ for all the geometries utilised 
ai*e illustrated in Figure 4.15 without fiuther discussion.
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Figure 4.14. Fractional contribution in percent of neutrons and induced photons to 
the absorbed dose in each organ for the AP irradiation orientation.
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Figure 4.15. Fractional contribution in percent of neutrons to the absorbed dose in 
each organ for the AP, PA, and LAT irradiation orientations.
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4. B. Zubal Complete model with added arms and legs
4.1. B. Dose calculation
The calculated fluence-to-absorbed dose conversion coefficients in units of pGy cm^ 
are listed in Tables 1-21 (appendix F) for the 21 organs from Zubal complete model. 
The uncertainties associated with the simulation results using F6 tally (Kerma 
approximation) are less than 1 % and not provided in the tables. However, the 
propagated statistical uncertainties for the effective dose calculation are provided in 
the next section. These uncertainties are based on the transport of approximately 30- 
70 million particles for the studied irradiation geometries, depending on the energy 
of the particles and the specific geometry.
Reduction on the uncertainties compared to Zubal head-torso part is due to the use 
of the MCNPX which offer better capabilities and faster heating tally (F6) to 
calculate dose in lattice geometiy based on kaima approximation. Figures 4.16-4.19 
show absorbed doses for the organs studied, noimalised per unit incident neutron 
fluence, as a function of particle energy. The general characteristics for organs 
absorbed doses seen in Figures 4.1-4.3 for organs doses discussed earlier on 
section 4.1 can be applied for the Zubal complete model. As have been mentioned 
before an absorbed dose curve could be roughly divided into three main parts. In the 
first part, the absorbed dose decreases rapidly as the energy reduces from 10 MeV to 
about 100 keV, and then, in the second pai't, is maintained approximately constant 
until about 10~^  MeV, for all irradiation geometiies. In the third part, thus for 
energies below 10"  ^MeV (tlieimal), the absorbed dose drops again but not so rapidly 
(as in the first paii). The PA orientation cuiwe lies between the cmves for the other 
two orientations for the majority of the organs studied. This indicates that iiradiation 
from the back of the body results in an absorbed dose wliich is lower than that 
resulting from iiradiation from the front, and yet is liigher than that resulting from 
LAT geometry. On the other hand, in the cases of the organs lying on the back, 
irradiation firom the PA orientation results in the highest absorbed dose compared 
with the other geometiies, hence, it is reasonable to receive higher doses when the 
body is hradiated firom the back (PA), relative to other irradiation geometries.
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Figure 4.18. Oesophagus , bone, testes, spleen, colon and red bone marrow, 
absorbed dose per unit neutron fluence.
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4.2. B. Effective dose calculations for Zubal complete model and comparison 
with other models.
The calculated fluence-to-effective-dose conversion coefficients in units of pSv cm^ 
with function of neutron radiation weighting factor wr fi'om (ICRP60) and the new 
proposed fiinction fi*om (ICRP92) for AP, PA and LLAT irradiation geometry are 
listed in Table 4.3 with the relative eiTor in pai'enthesis resulting from propagated 
imceitainties in the organ’s absorbed doses.
Table 4.3 Neutron fluence-to-effective-dose conversion coefficients for AP , PA and 
LLAT using wr values fi'om ICRP60 and ICRP92, the relative eiTor is shown as (%).
AP PA LLAT
Energy (MeV) ICRP60 W r ICRP92 W r IC R P 60wr IC RP92wr IC RP 60wr ICRP92 W r
1.0x10'^ 3.7 (0.4) 1.88(0.4) 2.27(0.32) 1.13(0.32) 1.69(0.43) 0.85(0.43)
1.0x10“® 4.5 (0.25) 2.28(0.25) 2.798(0.29) 1.39(0.29) 1.98(0.23) 0.2(0.23)
1.0x10“^ 7.1(0.25) 3.55(0.25) 4.45(0.29) 2.22(0.29) 2.98(0.27) 1.5(0.27)
1.0x10"® 10.73(0.29) 5.36(0.29) 6.99(0.35) 3.49(0.35) 4.38(0.25) 2.2(0.25)
1.0x10“® 12.45(0.35) 6.22(0.35) 8.29(0.34) 4.14(0.34) 5.01(0.16) 2.5(0.16)
1.0x10“^ 12.54(0.27) 6.27(0.27) 8.57(0.33) 4.29(0.33) 5.07(0.36) 2.53(0.36)
1.0x10“® 12.4 (0.28) 6.2(0.28) 8.69(0.31) 4.34(0.31) 4.97(0.36) 2.48(0.36)
1.0x10“^ 15.72(0.24) 6.64(0.24) 10.95(0.3) 4.62(0.3) 6.28(0.29) 2.65(0.29)
1.0x10"^ 53.52(0.24) 24.39(0.24) 33.51(0.29) 15.27(0.29) 19.97(0.23) 9.1(0.23)
1.0x10" 224.23(0.26) 216.32(0.26) 110.65(0.22) 106.74(0.22) 75.8(0.41) 73.13(0.41)
0.5x10^ 518.06(0.18) 575.2(0.18) 385.49(0.15) 428.01(0.15) 286.28(0.09) 317.85(0.09)
1.0x10^ 556.97(0.15) 654.53(0.15) 450.41(0.14) 529.3(0.14) 350.61(0.08) 412.02(0.8)
2.0x10^ 587.7(0.13) 773.23(0.13) 516.42(0.06) 679.44(0.06) 420.33(0.06) 553.02(0.06)
From the calculated effective dose values, it can be deduced that AP irradiation 
yields the largest effective dose at all the energies studied in this work, compared 
with the other two geometries. An explanation for this has already been provided on 
earlier on section.
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Figure 4.20. Effective dose comparison in percent calculated for Zubal complete 
model and Zubal torso.
The difference between the Zubal complete and Zubal torso phantoms in terms of 
external shape and the amount of scattering originated or shielded due to the 
presence of the arms and legs while neutron interactions will have an important 
effect on organ absorbed doses and on effective dose calculation; these differences 
are illustrated in Figure 4.20 for neutron effective dose. The most significant 
differences (50-85%) are observed in the energy region between 1x10'^ and 1 MeV. 
These differences start decreasing to 50-30% for energies higher than 1 MeV and for 
thermal energies, differences of (10-30%) are observed. These differences are not 
only due to the variation on the external shapes but also due to the number of tissue 
where considered for calculating the effective dose (18 for the Zubal torso model and 
21 for Zubal complete model) and the size of some tissue for example skeletal 
muscle and bone.
Figure 4.21 illustrates the effect of using the new proposed value for wr (ICRP 92) 
(blue legend line) on the neutron effective dose as proposed will preserve the 
weighting factor for energy around IMeV and will reduce the effective dose from
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the previous wr (ICRP60) by half at energies lower than 1 MeV where most of the 
dose deposited is due to gamma rays. The same figure shows comparisons of 
effective dose calculated for Zubal complete model with MIRD phantom and imaged 
based VIP-Man. Graphically, differences between the results for the Zubal model 
and the MIRDA^IPMAN data for each irradiation orientation are provided in Figure 
4,22. For the whole energy range covered and for AP irradiation condition the 
difference between the Zubal voxel phantoms against the VIPMAN voxel phantom 
results ranged 10% to 41% and for the Zubal to MIRD phantoms the difference 
ranged from 11% to 29%. The variation between the Zubal voxel phantom and the 
MIRD-based ICRP74 was m the range of 7 % to 36% for the PA irradiation 
geometry. For the same irradiation geometry, the largest deviations were 0.2 % to 
23% between the Zubal voxel phantom and the VIPMAN voxel phantom. By 
contrast, the Zubal voxel phantom received lower neutron effective doses for AP and 
PA inadiation geometry than the VIPMAN voxel phantom and the MIRD phantom 
for incident neuti'on energies below 5 MeV. In the LLAT inadiation geometry, all 
the three phantoms seem to have quite a good agreement with maximum of 10% 
differences up to neutron energy of 1 MeV. For incident neutron energies above 
5MeV the Zubal voxel phantom received more effective dose than the other two 
models. Several sources for the observed variation can be attributed to the different 
amoimt of shielding for the internal organ, which is affected by topology of the other 
organs; therefore, some faults on segmentation for the Zubal voxel phantom may 
have led to these deviations, which have been indicated previously for red bone 
marrow. It should be noted that doses for the male breast were not tallied in this 
study; therefore, the breast absorbed dose contribution to effective dose calculations 
is zero. Also, the dose to gonads for the MIRD phantom is calculated as the average 
of total dose to testes and ovaires while this study considered male gonad dose only. 
Another source of variation can be attributed to the segmented skeletal bone. In this 
study, three tissue compositions were used for the identified segmented skeletal 
bone: cortical bone, red bone marrow and yellow bone marrow having densities of 
1.9 g.cm'^, 1.03 g.cm'^ and 0.98 g.cm'^ respectively, with an average density of 1.76 
g.cm"^, compared to the VIPMAN voxel phantom and the MIRD phantom having an 
average skeletal bone density of 1.5 g/cm^. Details about the segmentation error in 
the Zubal voxel phantom can be found in Kramer et al 2003.
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Figure 4.23 demonstrates selected examples of the calculated fluence-to-absorbed 
dose conversion coefficients for thyroid and stomach in units of pGy cm^ compared 
with the data documented in ICRP74 for MIRD-based model and by Bozkurt et al 
2000 for the VIPMAN voxel phantom. For the PA thyroid the MIRD phantom the 
variation is 50% to 54% less absorbed dose than the VIPMAN and the Zubal voxel 
phantoms while AP thyroid the Zubal phantom receives less absorbed dose than the 
two other models with maximum variation of 66% in the lower neutron energy 
range.
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Figure 4.23. Comparison of Zubal, VIPMAN and MIRD absorbed doses: (A) PA 
thyroid (B) AP thyroid (C) LLAT stomach (D) PA stomach.
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For LLAT stomachs, the variation in the absorbed dose for Zubal to the two other 
models is less than 15% except for lower neutron energy range. However, for PA 
stomach Zubal the difference is up to 80% less than the two other models, this 
difference starts to disappear with neutron energies above IMeV. The observed 
variation can be attributed to the different amount of shielding for the internal organ, 
which is affected by topology of the other organs. VIPMAN has been scaled to 
match the MIRD, however, each phantom has different organs orientations. Figure 
4.23 illustrate the dependence of the effective dose on the external shape of the 
model and less dependency on the organs topology i.e. internal field.
4.3. B. Effective dose calculations for Zubal complete model with different 
normalisation point.
Figure 4.24 illustrates the difference in the normalisation of the effective dose to the 
overall flux, near the heart and bladder. The two latter places where chosen because 
they resemble the most probable place where the personal dosimeter (e.g. TLD) is 
placed on the body. The definition of the effective dose with these normalization- 
points expected to be changed and comparison of the organs absorbed doses from 
the three type of calculations will not be included due to the fact that effective dose 
is directly proportional to absorbed dose for each organ.
The effect of noimalisation to the position that the dosimeters is places on the body 
and the overall flux is huge starting from > 50% up to 84% for the AP, 65% to 90% 
for the PA and 56% to 85% for the LAT. On the other hand, the differences from 
normalisation to dosimeter sites ‘neai-heart’ and ‘neai-bladder’ are less than 25 % ; 
10% and 20% for AP, PA and LAT respectively. These results reflect the relation of 
W/Î on the external radiation incident fields (ICRP publication 92). The current 
system of effective dose has been under constant review from ICRP not only 
regarding the implantation of new voxel phantoms to replace the MIRD phantom but 
also in dealing with definitions of effective dose which partly refers to the external 
and partly, to the internal field. Several references to the external and internal field 
have been suggested for this purpose (ICRP publication 92) and further investigation 
on this subject is beyond the scope of this study
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Chapter 5
Conclusion
A high-resolution aiitliropomorphic phantom (Zubal model head+ torso) and the 
MCNP Monte Carlo code (version 4C2), has been used to calculate site fluence-to- 
absorbed dose and fluence-to-effective dose conversion coefficients for neutrons with 
energies below 10 MeV. Twelve monodirectional monoenergetic neutron beams have 
been used in the energy range of 10“  ^ (thermal) to 10 MeV, under three different 
source in'adiation configurations: anterior-posterior, posterior-anterior, and left lateral. 
Dose calculations were perfonned for eighteen selected organs of the body, for which 
the ICRP/ICRU have set tissue-weighting factors for the determination of the 
effective dose.
The highest photon fractional contribution to absorbed dose occurs in organs located 
deep in the body, such as the pancreas and kidneys, at all energies investigated. The 
testes are the organs that contiibute the largest fr action to the total effective dose (over 
50% contribution at energy of 500 keV). Absorbed doses at higher neutron energies 
(>1 MeV) is primarily contributed from neufr ons, with fractions that vary above 90%, 
but as the incident particle energy decreases down to thermal energies, neutron 
contribution to absorbed dose decreases sharply to less than 5-10%.
Due to the fact that, in practice, neutron fields are rarely monoenergetic and extending 
over a wide energy range (for instance in a nuclear reactor or linear accelerator 
environments), an attempt has been made to calculate the absorbed dose from 
Maxwell fission spectrum using a MCNP built-in frmction. In most of the organs, 
absorbed doses calculated for all source geometiies are within the range of 5-8 pGy 
cm^. The relative fractional Neutron contribution to dose varies within the range of 
63-97% for all organs studied, while photon contribution varies correspondingly 
between 3-37%.
fri order to perform a comparison with existing similar studies (mathematical MIRD 
phantom and VIPMAN voxel phantom) the Zubal complete model with added arms 
and legs was implemented into the MCNPX 2.4.0 code. For the whole energy range
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covered and for AP irradiation conditions, the difference between the results of the 
Zubal voxel phantoms against the VIPMAN voxel phantom results ranged from 10% 
to 41% and for the Zubal to MIRD phantoms the difference ranged fi'om 11% to 29%. 
The variation between the Zubal voxel phantom and the MIRD-based ICRP74 was in 
the range of 7% to 36% for the PA irradiation geometry. For the same iiradiation 
geometry the largest deviations were 0.2 % to 23% between the Zubal voxel phantom 
and the VIPMAN voxel phantom.
In contrast, the Zubal voxel phantom received lower neutron effective doses for AP 
and PA irradiation geometry than the VIPMAN voxel phantom; and the MIRD 
phantom for incident neutron energies below 5 MeV. However, all the tliree phantoms 
in the LLAT irradiation geometry seem to show quite a good agreement (with 
maximum of 10% differences) up to neutron energy of 1 MeV. For incident neutron 
energies above 5MeV the Zubal voxel phantom received more effective dose than the 
other two models. Several factors for the observed variation can be attributed to the 
different amount of shielding for the internal organ, which is affected by topology of 
the other organs; therefore, some faults on segmentation for the Zubal voxel phantom 
can lead to these deviations, which have been indicated previously for red bone 
maiTOW. It should be noted that doses for the male breast were not tallied in this 
study; therefore, the breast absorbed dose contribution to effective dose calculations is 
zero. A comparison in terms of organs absorbed doses show larger differences (< 
80%) than those have been observed from the comparisons of effective dose. The 
observed variation can be attributed to the different amount of shielding for the 
internal organ, which is affected by topology of the other organs. VIPMAN has been 
scaled to match the MIRD; however, each phantom has different organ orientation. 
Although VIPMAN voxel-based phantom in good agreement with the MIRD 
phantom, the comparison with organ absorbed doses indicated the strong dependency 
of effective dose on the external field of the phantom.
The results illustrate partial agreement between the Zubal and the VIPMAN voxel 
phantoms and the MIRD phantom. Voxel phantoms are more realistic than the MIRD 
mathematical phantom, but they reflect individuals and are only applicable to a 
subject with similar physical shape.
Many groups of authors (Table 1.4) have developed voxel phantoms from different 
ethnic groups (Caucasian, Japanese, and Korean) and more might emerge in future 
years. Voxel based tomographic phantoms can be argued to be more realistic than the 
mathematical phantoms. The voxel phantoms have the flexibility to be scaled to a 
certain degree to match an individual. However, dose calculations must be interpreted 
with gi'eat care if  they have to be applied for a similar person. The inherent drawback 
of voxel phantom arises from the difficulties of obtaining segmented images m a short 
time.
Both of the voxel phantoms compared in this study (VIPMAN & Zubal) were 
segmented manually which involves many steps and requires a long period of time. 
Some authors (Zankl and Wittmaim 2001) used the CT number from the CT 
tomographic image as a method to distinguish different tissues/organs in the body 
based on the gr'ey scale values. The downside of this method arises from the 
possibility of under or over estimation of organs sizes (10-25 %) (Goan, 2004). 
Development of this method and other faster or automated segmentation techniques 
will make the use of voxel phantoms more effective in radiation applications (i.e. 
radiotherapy) and much less time consuming.
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Future work
Voxel-based tomographic anthropomorphic phantoms will have wider applications in 
the near future not only in the fields of health physics, dosimetry and radiation 
protection but also important in radiation therapy. One of the major characteristics of 
the voxel-based tomographic phantom is that they reflect individuals, therefore, with 
the advancement in computer, data from a CT or MRJ for patients undergoing 
radiation therapy can be transferred directly to suitable Monte Carlo codes for precise 
dose calculations. This translation can be very time consuming, however, the growing 
need for the voxel-based tomographic phantoms have led to an improvement of the 
segmentations and translation methods to the Monte Carlo codes.
A high-resolution voxel-based anthropomorphic phantom of the eye was developed 
by the medical physics group at Surrey University (Alghamdi et al 2005) based on 81 
slices obtained from female data of the Visible Human project. Manual segmentation 
was carried out by colour labelling of each pixel. As a result, 15 identified structures 
were assigned with 15 ID numbers and the entire phantom was adapted into MCNPX 
code following the same methodology explained in chapter 2 for a forecast proton 
simulation study. The data is represented as 256x256x81 with a voxel size of 0.33 
mm^. Each slice was segmented with different colour-intensity to contrast of the 
various organs/tissues in the original images as shown in Figure 5.1.
Figure 5.1. The visible human female phantom. A) original phantom image before 
segmentation. B) Segmented eye.
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The corresponding ID numbers can be seen in the MCNPX model in Figure 5.2 with 
a disc source and a compensator for an initial proton beam simulation. A cylindrical 
mesh tally was used to calculate the total energy deposition and the result are 
provided in Figure 5.3.
So far, this phantom has the finest resolution compared to other phantoms used in 
proton therapy simulation. Further adjustment and modification of the current model 
is necessary for ultimate comparison with treatment planning systems used in proton 
therapy of the eye. Application of this phantom can be extended for quality assurance 
purposes and for further investigation of possible field mapping by imaging the 
photon product of proton nuclear interactions.
CeU Tissue Volume
(cm')
1 Air inside 9^3
2 Bone 14.84
3 Brain 29.51
4 Fat 33.70
5 Muscle 17.74
6 Ligament 0.05
7 Cornea 0.18
8 Eye gel 7.58
9 Lens 0.24
10 Lachrymal duct 0.03
11 Optical nerve 0.63
12 Other* 4.30
13 Sclera 1.00
14 Skin 1.80
199 Air outside 69.81
*Blood and blood vessels
Figure 5. 2. The geometry setup of the eye phantom, disc source (cell #1006) and the 
Perspex compensator (cell #1005) plotted using the MCNPX plotting feature. The 
table on the right provides list of important tissues identified and their volumes.
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Figure 5.3. A plot of the fine mesh used to score total energy deposition on the eye 
phantom as plotted using DDL.
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v ^ p e n d i x  A
The C program used to read Zubal Head-torso part 
File name: Readfile.c
#include <stdlib.h>#include <stdio.h>
#define length 16384 main{){int count,countl,repeat,slength,valuel,value2;char buf[length],string[80],cl,c2,filein[80],fileout[80];FILE * fp,* output;
printf("Please enter the name of the input file\n"); scanf{"%s",filein);printf("Please enter the name of the output file\n"); scanf{"%s",fileout);
if((output=fopen(fileout,"w"))!=NULL)printf("\nYoupppii!\n");/*opening new file (destination file)*/
/*opening the original file*/ if((fp=fopen(filein,"r"))!=NULL)
{/*looping on the number of slices*/ for(count=0;count<243;count++)
{/* read one buffer of 16384 (128*128) characters*/ if(fread(buf,sizeof(char),length,fp)!=length)exit(1); repeat=l;/*sprintf(string,"%3d ",count+1);*/sprintf(string," ");slengths5 ;/*looping on the values of the matrice [128*128]*/ for(countl=0;countl<16383;countl++)
{cl=*(buf+countl); c2=*(buf+countl+1) ; valuel=cl; value2=c2;/*if(cl!=NULL)*//*fprintf(outputl,"\n%d\t%d\t%d\t%d",count,countl,cl,c2);*//*comparing two successif values if they are equal we increment by one the value called repeat if not we go and write on the string*/ if(valuel==value2){ repeat++;
/*printf("\nl-are equal %d %d",repeat,cl);*/
}/*if(valuel==value2&&countl==16382)repeat++;*/ else {/*printf("\nare not equal %d %d %d %d %d",repeat,cl,c2,valuel,value2);*/ locationl: ; slength=slength+10;
107
if{slength<8 0 ){/*writing on the string the information of how many times the value is repeated taking care that when we write this information it won't exceed 80 characters */sprintf(string+slength-10,"%3d %5dr ",cl,repeat);
}else
{ fprintf(output,"%s\n",string);/* sprintf(string,"%3d ",count+1);*/sprintf(string," ");slength=5; goto locationl;
}repeat=l;}/*closing if(valuel==value2)else *//*printf("\n2-are equal %d %d",repeat,cl);*/}/* closing for(countl=0;countl<16383;countl++)*/ location2: ; s1ength= s1ength+10 ; if(slength<80)
{ sprintf(string+slength-10,"%3d %5dr ", cl,repeat);
}else
{ fprintf(output,"%s\n",string);/* sprintf(string,"%3d ",count+1);*/sprintf(string, " " ) ;slength=5; goto location2;
) fprintf(output,"%s\n",string);}/* closing for(count=0;count<243;count++)*/}/* closing if((fp=fopen("voxel_man.dat","r"))1=NULL) */ fclose(fp); fclose(output);}/*closing the main*/
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Appendix B
A sample of IDL code used for Zubal with added arms and legs.
***********************************************************************
This function converts the Zubal phantom into MCNP geometry cards, 
note: the value for outside phantom will be modified to 199.
***********************************************************************
FUNCTION mcnp, phantom 
©zubalConstants
outFile = DIALOG_PICKFILE( GET_PATH=path, TITLE='Output file for MCNP:' 
)
IF ( outFile NE ■■ ) THEN BEGIN
OPENW, lun, outFile, /GET_LUN
phantomSize = N_ELEMENTS( phantom )newLine = ' 'line = newLinecounter = OLoldVal = -1i = OL
WHILE ( i LT phantomSize ) DO BEGIN newVal = FIX( phantom[i] )IF { newVal EQ 0 ) THEN newVal = 199
IF { newVal EQ oldVal ) THEN BEGIN
increment the counter of repetitions
counter = counter + IL ENDIF ELSE BEGIN
append the repetition counts (counter) and the new value (newVal) to the end of the current line (line).
IF ( counter GT OL ) THEN BEGINnewStr = ' ' + STRTRIM(counter,2) + 'r ' +STRTRIM(newVal,2)counter = OL ENDIF ELSE BEGINnewStr = ' ' + STRTRIM(newVal,2)
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I S
ENDELSE
lineWidth = STRLEN(line) + STRLEN(newStr) IF ( lineWidth LT 80 ) THEN BEGIN line = line + newStr ENDIF ELSE BEGINPRINTF, Inn, line line = newLine + newStr ENDELSE
ENDELSE ; newVal=oldVal
increment i, phantom is accessed first in x-, then y- and then z-directions (cf. IDL array storage)
i = i + IL
oldVal = newVal ENDWHILE ; i<phantomSize
; at the end of the loop, the last element (phantom[phantomSize-l])
read and there are 2 cases ;
1) phantom[phantomSize-1] = phantom[phantomSize-2]:the counter is updated but NO preparation for printing tofile
which
2) phantom[phantomSize-1] <> phantom[phantomSize-2]:2.1) line shorter than 80:line contains the new value but NOT printed to file.2.2) line too long:second last line is printed to file but NOT the last
contains the new value.
IF ( phantom[phantomSize-1] EQ phantom[phantomSize-2] ) THEN BEGIN newStr = ' ' + STRTRIM(counter,2) + 'r 'IF ( STRLEN(1ine)+STRLEN(newStr) LT 80 ) THEN $PRINTF, lun, line+newStr $ELSE $PRINTF, lun, line, newLine+newStr ENDIF ELSE $PRINTF, lun, line
FREE_LUN, lun RETURN, 1 ENDIF ELSE $RETURN, 0
END ; function mcnp
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^pendix C
A sample of MCNP4C2 input file starting from surface cardC Cell Surfaces7 px 0.08 px 0.409 py 0.010 py 0.4011 pz 0.012 pz 0.40c lattices side301 px 0.40302 px 0.0303 py 0.40304 py 0.0305 pz 0.40306 pz 0.0c array siz1 px 51.202 px 0.03 py 29.204 py 0.05 pz 94.406 pz 0.0c Sphere of Air including the phantom 200 s 25.6 14.6 47.2 130
mode n p e c c3 c5 c7 cll c28 c33 c36 c38 c42 c432] 6589 j 1471 j 35797 3j 16 16] 14 4] 31 2j 5 j 747 3] 1415 248269 884 2] 38 3 368 7j 152 1279 3j 72 3]c44 c45 c48 c49 c50 c58 c59 c63
c
v o l
c c cc SOURCE - LEFT LATERAL ORIENTATION csdef x=-l y=dl z=d2 erg=0.000001 dir=l vec=l 0 0 sil -1.0000001 -1 30 30.0000001 spl 0 1 1 0si2 -1.0000001 -1 95 95.0000001 sp2 0 1 1 0 c c
c Tally *f6 for ENERGY deposition averaged over a cell (units: Jerks/g = 10^9 Joules/g).cc*f36:n (3<2)*f38:p,e (3<2) 
* f 5 6 : n  (5<2)*f58;p,e (5<2) *f76:n (7<2)*f78:p,e (7<2)
$ skin 
$ brain
$ sceletal muscle
111
*fll6:n (11<2) $ eye*fll8:p,e (11<2)*f286:n (28<2) $ trachea* f 2 8 8 : p , e (28<2)*f336:n (33<2) $ oesophagus
* f 3 3 8 : p , e (33<2)*f366 :n (36<2) $ thyroid*f368;p,e (36<2)*f386:n (38<2) $ lung*f388:p,e (38<2)*f426:n (42<2) $ liver*f428:p,e (42<2)*f436:n (43<2) $ stomach*f438:p,e (43<2)*f446:n (44<2) $ spleen*f448:p,e (44<2)*f456:n (45<2) $ colon*f458:p,e (45<2)*f486:n (48<2) $ pancreas*f488:p,e (48<2)*f496:n (49<2) $ adrenals*f498:p,e (49<2)*f506 :n (50<2) $ kidney*f508:p,e (50<2)*f586 :n (58<2) $ bladder*f588:p,e (58<2)*f596:n (59<2) $ rectum*f598:p,e (59<2)*f636 :n (63<2) $ testis*f638:p,e (63<2)ccc Tally f4 for track lenght estimate of CELL FLUX {units: particles/cm''2 ) . c cf 34 ;n (3<2) $ skinf54 :n (5<2) $ brainf74:n (7<2) $ sceletal musclefll4:n (11<2) $ eyef284:n (28<2) $ tracheaf334:n (33<2) $ oesophagusf364:n (36<2) $ thyroidf384 :n (38<2) $ lungf424:n (42<2) $ liverf434:n (43<2) $ stomachf444:n (44<2) $ spleenf454 :n (45<2) $ colonf484:n (48<2) $ pancreasf494 :n (49<2) $ adrenalsf504:n (50<2) $ kidneyf584:n (58<2) $ bladderf594;n (59<2) $ rectumf634:n (63<2) $ testis
c material composition of soft tissueml 1001.60c -0.10454 6000.60c -0.22663 7014.60c -0.02490
112
8016.60c -0.63525 11023.60c - 16032.60c -0.00204 17000.60c - mtl Iwtr.Olt c material composition of lung tissue m2 1001.60c -0.10134 6000.60c -8016.60c -0.75752 11023.60c - 17000.60c -0.00266 19000.60c - mt2 Iwtr.Olt c material composition of bone tissue m3 1001.60c -0.07337 6000.60c -8016.60c -0.47893 11023.60c - 15031.60c -0.05095 16032.60c - 19000.50c -0.00153 20000.60c - mt3 Iwtr.Olt
0 .0 0 1 1 20.00133 15031.60c19000.60c
0.10238 7014.60c0.00184 16032.60c0.00194
0.25475 7014.60c0.00326 12000.60c0.00173 17000.60c0.10190
-0.00134-0.00208
■0.02866-0.00225
■0.03057
- 0 . 0 0 1 1 2■0.00143
airm4 6000.60c 0.000124 18000. 0.012827 7014.60c 0.755267 8016.60c 0.231781
ctme 720 c nps 10000 c prdmp j 500000 print 30 -60 J  J
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T^pendix D
A sample of the MCNPX4.2.0 file for Zubal complete model starting from surface cardc BLANK LINE
BLANK LINEn = number of pixels per row of square image R = resolution of image (cm/pixle) z = number of axial slices Z = height of axial slice
c The external boundaries below will change only with the patient,c not image size (because the resolution is changings as well)111 px -28.44 $ Should be -nR/2 lattice boundary112 px 0.0 $ Should be 0.0 single voxel boundary113 px 0.36 $ Should be R single voxel boundary114 px 28.44 $ Should be nR/2 lattice boundary
211 py -13 .32212 py 0.0213 py 0.36214 py 13.32
311 pz -87.84 $ Should be -zZ/2312 pz 0.0313 pz 0.36314 pz 88.20 $ Should be zZ/2
1000 so 130.0 $ Same as Alghamdi's70 so 130.0 $ ditto
c Surfaces for tallies1015 rpp -28.08 28. 08 -13.33 -13.32 -87.48 87.841025 rpp -28.08 28. 08 13.32 13.33 -87.48 87.841035 rpp 28.44 28. 45 -12.96 12.96 -87.48 87.84c BLANK LINE
c BLANK LINE
imp;n 2 90r 1 3r 0imp:p 2 90r 1 3r 0
c Material compositions
c soft tissueml 1001.60c -0.105 6000.60c -0.125 7014.60c -0.0268016.60c -0.735 11023.60c -0.002 15031.60c -0.00216032.60c -0.0018 17000.60c -0.0022 19000.60c -0.002120000.60c -0.0001 26054.60c -0.0001 53129.60c -0.0001mtl Iwtr.Olt
lungm2 1001.60c -0,103 6000.60c -0.105 7014.60c -0.0318016.60c -0.749 11023.60c -0.002 15031.60c -0.002 16032.60c -0.003 17000.60c -0.003 19000.60c -0.002
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mt2 Iwtr.Oltcc bonem3 1001.60c -0.034 6000.60c -0.155 7014.60c -0.0428016.60c -0.435 11023.60c -0,001 12000.60 -0.002 15031.60c -0.103 16032.60c -0.003 20000.60c -0.225 mt3 Iwtr.Oltcc airm4 6000.60c 0.000124 7014.60c 0.755267 8016.60c 0.23178118000. 0.012827cc Red bone marrowm5 1001.60c -0.105 6000.60c -0.414 7014.60c -0.0348016.60c -0.439 15031.60c -0.001 16032.60c -0.002 17000.60c -0.002 19000.60c -0.002 26054.60c -0.001 mt5 Iwtr.Oltcc Yellow bone marrowm6 1001.60c -0.115 6000.60c - 0 . 6 4 4  7014.60c - 0 . 0 0 7  8016.60c -0.231 11023.60c -0.001 16032.60c -0.001 17000.60c -0.001 mt6 Iwtr.Oltcc Musclem7 1001.60c - 0 . 1 0 2  6000.60c -0.143 7014.60c -0.0348016.60c -0.71 11023.60c -0.001 15031.60c -0.00216032.60c -0.003 17000.60c -0.001 19000.60c -0.004 mt7 Iwtr.Oltcc Skinm8 1001.60c -0.10 6000.60c -0.204 7014.60c -0.0428016.60c -0.645 11023.60c -0.002 15031.60c -0.001 16032.60c -0.002 17000.60c -0.003 19000.60c -0.001 mt8 Iwtr.Oltcc Adipose
m9 1001.60c -0.114 6000.50c -0.598 7014.60c -0.078016.60c -0.278 11023.60c -0.001 16032.60c -0.00117000.60c -0.001 mt9 Iwtr.Oltcc CartilagemlO 1001.60c -0.096 6000.60c -0,099 7014.60c -0.0228016.60c -0.744 11023.60c -0.005 15031.60c -0.022 
1 6 0 3 2 . 6 0 c  -0.009 17000.60c -0.003 mtlO Iwtr.Oltc
# vol
j $ cell 10006 1 2 5 . 0 9 $ skin228.754 $ brain175.053 $ spinal cord477.617 $ skull820.912 $ spine1385.68 $ rib cage & sternum671.007 $ pelvis
115
3030.63 $ long bones34349.5 $ skeletal muscle2909.65 $ lungs436.420 $ heart1365.95 $ liver15.3498 $ gall bladder355.425 $ kidney15.4898 $ pharynx29.9532 $ esophagus239.485 $ stomach1233.91 $ small bowel8 5 3 . 0 5 8 $ colon36.9516 $ pancreas2.89267 $ adrenals15304.4 $ fat982.062 $ blood pool147.760 $ gas (bowel)24.6344 $ fluid (bowel)548.068 $ yellow bone marrow839.015 $ red bone marrow4.89888 $ thyroid55.1474 $ trachea41.9904 $ cartilage259.781 $ spleen307.790 $ urine52.9079 $ feces69.0042 $ testes20.4353 $ prostate68.4444 $ rectum211.258 $ diaphragm146.826 $ bladder42.6902 $ lesion2.65939 $ dens of axis76.2826 $ jaw bone32.9391 $ parotid gland2.65939 $ lacrimal glands12.3638 $ spinal canal30.5597 $ hard palate149.486 $ cerebellum53.9343 $ tongue13.3436 $ horn of mandible6.15859 $ nasal septum
5 2 9 . 1 7 2 $ white matter15.0232 $ superior sagittal sinus4.61894 $ medulla oblongata4.71226 $ artificial lesion123.452 $ frontal lobes22.6748 $ pons9.84442 $ third ventricle0.00000 $ pineal body73.0633 $ occipital lobes7.55827 $ hippocampus0.00000 $ pituitary gland452.610 $ fat (head)0.886464 $ uncus (ear bones)5.73869 $ turbinates11.1508 $ caudate nucleus
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8.4913913.5769 180.652 10.5443 1.53965 9.93773I.35302II.6173 10.450913.5769 8.35142 
3 . 9 6 5 7 6  245.551 1.77293 4.66560 123.965 4.24570 14.6966 4.012420.373248 0.606528
$ zygoma $ insula cortex $ sinuses/mouth cavity $ putamen $ optic nerve $ internal capsule $ septum pellucidium $ thalamus $ eyeball $ corpus collosum $ special region frontal lobes $ cerebral falx $ temporal lobes $ fourth ventricle $ frontal portion eyes $ parietal lobes $ amygdala $ eye$ globus pallidus $ lens$ cerebral aquaduct10. 0310 $ lateral ventricles53. 9810 $ prefrontal lobes10. 1244 $ teeth7j $ cell 199 and the rest
mode n pctme 720prdmpc j -60 1 $ dump once every hour andcc neutron source, AP irradiation. Maxwell fission i
sdef erg=d3 x=dl y=-18.0 z=d2vec=0.0 1.0 0.0 dir=1.0sil -28.08 28.08spl 0.0 1.0si2 -87.48 0.0 87.84sp2 0.0 1.0 1.0sb2 0.0 2.0 1.0sp3c
-2
fcl6 skinf 16 ;n (1<1000)fc516 skinf516:p (KIOOO)
fc26 brainf25 :n ((2 77 83 85 89 91 92 95 96 101 103 105 : 108 109 111 113 114 115 117 118 120 122fc526 brainf526:p ((2 77 83 85 89 91 92 95 96 101 103 105 : 108 109 111 113 114 115 117 118 120 122
fc96 skeletal musclef96 :n (9<1000)fc596 skeletal muscle
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f596:p (9<1000)cfcll6 eyefll6:n ((110 116 119 121)<1000)fc616 eyef616:p ((110 116 119 121)<1000)cfc296 trachea f296:n (29<1000)fc796 trachea f796:p (29<1000)cfcl66 oesophagus fl66:n (16<1000)fc666 oesophagus f666:p (16<1000)cfc285 thyroids f286:n (28<1000)fc785 thyroids f786;p (28<1000)cfcl06 lungsfl06:n (10<1000)fc606 lungsf606:p (10<1000)cfcl26 liverfl26:n (12<1000)fc626 liverf626:p (12<1000)cfcl76 stomach fl76:n (17<1000)fc676 stomach f676:p (17<1000)cfc316 spleen f316:n (31<1000)fc816 spleen f816:p (31<1000)cfcl96 colonfl96:n (19<1000)fc696 colonf696:p (19<1000)cfc206 pancreas f206:n (20<1000)fc706 pancreas f706:p (20<1000)cfc216 adrenals f216:n (21<1000)fc716 adrenals f716:p (21<1000)c
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fcl46 kidneys fl46:n (14<1000)fc646 kidneys f646;p (14<1000)cfc406 bladder f406:n (40<1000)fc906 bladder f906:p (40<1000)cfc376 rectum f376:n (37<1000)fc876 rectum f876:p (37<1000)cfc346 testes f346:n (34<1000)
fc846 testes f846;p (34<1000)cfc276 red bone marrow f276:n (27<1000)fc776 red bone marrow f776:p (27<1000)cfc46 bonesf46:n ( ( 4  5 6 7 8 70 71 81 99 100 102 125)<1000)fc546 bonesf546:p ((4 5 6 7 8 70 71 81 99 100 102 125)<1000)cfcl86 small intestinefl86:n (18<1000)fc686 small intestinef686:p (18<1000)cfc4 incidence flux {overall average) f4;n 1015cfcl4 incidence flux (near bladder) fl4:n (1 9 9 < 1 0 0 0 [ 0 , - 2 5 , - 2 5 ] )sdl4 0.046656cfc24 incidence flux (near heart and lung) f24:n (199<1000[15,-30,-125])sd24 0.046656
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i^pendix E
Absorbed dose per unit fluence D ^ /#  and statistical uncertainty U
9^ê) from monoenergetic neutrons under various orientations for Zubal (head4- 
torso).
1- S k in
AP PA LAX
iUeV) Dt/O U(% ) Dt/<E» U(% ) Dt/0> U(% )
1.0x10"® 1 . 2 0.15 1 . 1 0 . 1 2 0.9 0.14
1.0x10"® 1.4 0.15 1.3 0 . 1 2 1 . 0 013
1.0x10"? 1.4 0.15 1.3 0.13 1 . 1 0.13
1.0x10"® 1.5 0.16 1.4 0.14 1 . 1 0.17
1.0x10"® 1 . 6 0.16 1.4 0.14 1 . 1 0.17
l.OxlO'4 1.5 0.16 1.3 0,14 1 . 1 0 . 1 1
1.0x10"® 1.4 0.15 1.3 0.15 1 . 0 0.18
1.0x10"? 1 . 6 0.14 1.4 0.14 1 . 1 0.17
1.0x10"! 2.7 0.08 2.5 0.08 2.3 0.08
1.0x10“ 9.8 0.05 9.5 0.05 7.7 0.05
O.Sxlo! 24.0 0.05 23.7 0.05 19.9 0.05
l.O x lo ! 39.4 0.05 37.8 0.05 36 0.06
i n
t r y *  mi
AP PA LAXnnergy
(MeV) Dt/O U(% ) Dt/O U(% ) Dt/<& U(% )
1.0x10"® 1 . 2 0.83 1.5 0.7 2 . 0 0.54
1.0x10"® 1.4 0.84 1.9 0.69 2.3 0.51
1.0x10"? 1.4 0 . 8 1 . 8 0.67 2 . 2 0.48
1.0x10® 1.4 0.78 1.7 0,66 1 . 8 0.53
1.0x10"® 1.3 0.78 1.5 066 1 . 6 0.53
1.0xl0"4 1 . 2 0.79 1.4 0 . 6 6 1 . 6 0.35
1.0x10"® 1 . 1 0.71 1.3 067 1.4 0.55
1.0x10"? 1 . 1 0.71 1 . 2 0 . 6 8 1.4 0.55
1.0x10"! 1.3 0.61 1.5 0.57 1.5 0.39
1.0x10“ 4.5 0.33 5.2 0.31 6.6 0.23
0.5x10! 2 0 . 1 0.26 21.9 0.25 24.8 0 . 2
l.O x lo ! 36.1 0.28 36.4 0.28 41 0.23
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3 - S k e le ta l m u sc le s
AP PA LAT
4- Eye
(MeV) Dt/O U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10'® 1.3 0.16 1.9 0.14 1 . 1 0.15
1.0x10“® 1.5 0.16 1 . 8 0.14 1 . 2 0.15
1.0x10"? 1.4 0.16 1 . 8 0.13 1 . 2 0.14
1.0x10'® 1.5 0.14 2.0 0.13 1 . 1 0.16
1.0x10'® 1.4 0.14 1 . 8 0.13 1 . 0 0.16
l.OxlO'4 1.4 0.15 1.7 0.13 1 . 0 0 . 1 1
1.0x10'® 1.4 0.14 1.7 0.14 1 . 1 0.16
1.0x10'? 1.5 0.13 1 . 6 0.13 1 , 2 0.17
1.0x10'! 1 . 6 0 . 1 1 1 . 8 0 . 1 1 1.7 0 . 1 2
1.0x10“ 5.3 0.07 5.7 0.06 4.3 0.07
O.Gxlo! 17.3 0.06 19.1 0.04 15.4 0.05
l.OxlO! 30.7 0.06 30.8 0.05 27.2 0.07
AP PA LATHinergy
(MeV) Dt/O U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10'® 2.3 3.14 0.7 9.13 1 . 1 3.57
1.0x10'® 2.5 3.07 0 . 8 8 . 8 1 . 2 3.42
1.0x10'? 2 . 6 3.25 0 . 8 8 . 2 2 1 . 2 3.41
1.0x10'® 2.9 3.54 0 . 8 7.99 1 . 2 3.89
1.0x10'® 3.5 3.81 0,7 7.83 1 . 1 3.99
1.0x10 '“* 3.8 4.08 0.7 8.25 1 . 1 2.65
1.0x10'® 3.7 3.73 0.7 8.03 1 . 0 4.4
1.0x10'? 3.7 3.12 0 . 8 7.6 1.3 4.14
1.0x10'! 6 . 0 1.33 2 . 1 7.47 2.8 2.12
1.0x10° 1 1 . 0 0.72 7.6 4.47 8.7 0.9
O.Gxlo! 30.2 0.67 21.4 1.16 27.9 0 . 8
l.O x lo ! 46.4 0.79 35.1 1 . 2 2 43.2 1 . 0 1
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5- T rach ea
Energy _ AP PA LAT
iMeV) D t/O U(% ) D t/ O U(% ) D t/ O U(% )
1.0x10"^ 4.9 2.22 2.7 2.9 1.5 2.75
1.0x10"® 5.8 2.11 3.3 SL86 1.7 2.63
1.0x10"^ 6.3 2.05 3.6 2.71 1.8 2.59
1.0x10® 6.1 1.95 3.7 2.56 1.8 2.85
1.0x10"® 5.4 1.93 3.3 2.48 1.7 2.79
1.0x10"^ 4.6 1.95 2.9 2.4 1.5 1.79
1.0x10"® 3.8 1.76 2.7 2.37 1.4 2.77
1.0x10"® 3.7 1.75 2.5 2.29 1.4 2.73
1.0x10"^ 2.8 1.49 2.4 2.26 1.5 2.35
1.0x10° 4.7 0.63 3.5 1.38 2.9 1.27
0.5x10^ 18.2 0.39 14.1 0.51 12.3 0.52
1.0x10^ 29.7 0.46 25.9 0.53 24.7 0.58
6- O eso p h a g u s
AP PA LATü n eigy
(MeV) D t/ O U(% ) D t/ O U(% ) D t/ O U(% )
1.0x10“® 5.4 3.08 3.9 2.88 1.9 3.37
1.0x10"® 6.0 2.97 4.2 2.71 2.2 3.36
1.0x10"? 6.3 2.78 4.4 2.63 2.5 3.16
1.0x10"® 6.3 2.64 4.7 2.5 2.6 3.44
1.0x10"® 6.0 2.55 4.8 2.4 3.0 3.48
1.0x10"“* 5.3 2.49 4.2 SL37 3.2 2.09
1.0x10"? 4.6 2.2 3.6 2.29 3.2 3.2
1.0x10"? 4.0 2.19 3.2 2.19 2.7 3.25
1.0x10"! 3.3 2.1 2.6 2.16 2.4 2.8
1.0x10“ 3.2 1.18 2.7 1.35 3.2 1.76
0.5x10! 12.3 0.41 12 0.45 9.2 0.49
l .O x lo ! 23.1 0.46 21.7 0.48 22.7 0.54
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7“ Thyi*oids
AP PA LATü iiergy *- 
(MeV) Dt/O U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10“® 2.2 5.29 2.0 7.47 1.0 7.42
1.0x10“® 2.2 5.14 2.2 7.34 1.1 7.11
1.0x10“? 2.4 4.7 2.3 (183 1.2 7.46
1.0x10“® 2.7 4.54 2.4 6.98 1.3 8.83
1.0x10“® 2.9 4.67 2.5 6.65 1.4 8.48
1.0x10““* 3.1 4.72 2.7 6.59 1.3 5.24
1.0x10“? 8.2 4.28 2.7 6.39 1.2 8.33
1.0x10“? 3.3 4.27 3.0 6.11 1.2 7.95
1.0x10“! 3.8 3.27 3.3 5.86 1.4 6.68
1.0x10° 5.7 1.18 4.6 3.74 3.0 4.93
0.5x10* 21.5 0.87 15.4 1.2 11.9 1.43
l.OxlO! 31.8 0.96 24.6 1.21 23.3 1.54
8 -  L u n gs
AP PA LAT
(MeV) Dt/ ^ U(% ) Dt/<& U(% ) Dt/O U(% )
1.0x10“® 2.2 0.62 1.9 0.61 1.1 0.65
1.0x10'® 2.6 0.61 2.1 0.59 1.3 0.63
1.0x10“? 2.6 0.57 2.2 0.55 1.7 0.59
1.0x10“® 2.7 0.54 2.2 0.53 1.8 0.65
1.0x10“® 2.7 0.52 2.3 0.51 1.7 0.62
1.0x10““* 2.6 0.52 2.4 0.49 1.9 0.4
1.0x10“? 2.3 0.47 2.2 0.49 1.9 0.61
1.0x10“? 2.1 0.47 2.0 0.49 1.8 0.62
1.0x10“! 2.5 0.43 2.2 0.46 1.9 0.53
1.0x10° 4.1 0.21 5.6 0.23 3.6 0.27
0.5x10* 15.6 0.11 17.8 0.11 12.2 0.14
1.0x10* 27.2 0.14 32.1 0.14 24.1 0.17
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9 “ L iver
Energy
(MeV)
AP PA LAT
Dt/O U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10“® 4.2 0.58 2.4 0.7 1.7 0.43
1.0x10“® 4.5 0.55 2.4 0.68 1.9 0.41
1.0x10“? 4.6 0.51 2.5 0.63 2.0 0.37
1.0x10“® 4.7 0.48 2.6 0.6 2.1 0.4
1.0x10“® 4.7 0.47 2.6 0.58 2.1 0.39
1.0x10““* 4.2 0.46 2.4 0.56 2.0 0.25
1.0x10“? 3.8 0.42 2.2 0.55 1.8 0.38
1.0x10“? 3.5 0.4 2.1 0.54 1.7 0.39
1.0x10“! 3.1 0.38 2.0 0.52 1.7 0.32
1.0x10" 8.8 0.23 3.5 0.33 3.1 0.19
0.5x10* 15.1 0.16 13.4 0.19 12.1 0.15
1.0x10* 29.5 0.2 25.4 0.22 23.2 0.18
l o -  S to m a ch
Energy AP PA LAT
(MeV) Dt/<I> U(% ) Dt/O U(% ) Dt/ 0 U(% )
1.0x10“® 4.2 0.58 2.4 0.7 1.7 0.43
1.0x10“® 4.5 0.55 2.4 0.68 1.9 0.41
1.0x10“? 4.6 0.51 2.5 0.63 2.0 0.37
1.0x10“® 4.7 0.48 2.6 0.6 2.1 0.4
1.0x10“® 4.7 0.47 2.6 0.58 2.1 0.39
1.0x10““* 4.2 0.46 2.4 0.56 2.0 0.25
1.0x10“? 8.8 0.42 2.2 0.55 1.8 0.38
1.0x10“? 3.5 0.4 2.1 0.54 1.7 0.39
1.0x10“! 3.1 0.38 2.0 0.52 1.7 0.32
1.0x10° 8.8 0.23 3.5 0.33 3.1 0.19
0.5x10* 15.1 0.16 13.4 0.19 12.1 0.15
1.0x10* 29.5 0.2 25.4 0.22 28.2 0.18
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11- S p lee n
AP PA LATünergy -  
(MeV) D t/O U (% ) D t/ O U (% ) D t/ O U (% )
1 .0 x 1 0 “® 1.8 1.67 2.4 1,16 0.7 3.68
1 .0 x 1 0 “® 1.9 1.63 2.6 1.1 0.8 3.4
1 .0 x 1 0 “? 2.0 1.52 2.7 1.04 0.8 3.18
1 .0 x 1 0 “® 2.1 1.42 2.7 0.98 0.9 3.37
1 .0 x 1 0 “® 2.1 1.36 2.8 0.95 1.1 3.16
1 .0 x 1 0 ““* 2.1 1.32 2.5 0.93 1.4 1.96
1 .0 x 1 0 “? 1.9 1.17 2.3 0.92 1.5 2.94
1 .0 x 1 0 “? 2.1 1.15 2.5 0.9 1.6 2.87
1 .0 x 1 0 “! 2.5 1.09 3.0 0.87 1.8 2.51
1 .0 x 1 0 ” 3.0 0.69 3.6 0.47 2.3 1.77
0.5x10* 12.3 0.38 14.0 0.32 10.3 0.51
1 .0 x 1 0 * 23.9 0.39 31.1 0.34 19.8 0.5
Ion
AP PA LATünergy ■ 
(MeV) D t/ O U (% ) D t/O U (% ) D t/O U (% )
1 .0 x 1 0 “® 1.6 0.59 1.2 0.96 0.7 0.68
1 .0 x 1 0 ® 1.9 0.56 1.3 0.92 0.8 0.64
1 .0 x 1 0 “? 1.9 0.52 1.3 0.86 1.0 0.59
1 .0 x 1 0 “® 2.0 0.49 1.4 0.8 1.0 0.63
1 .0 x 1 0 “® 2.1 0.47 1.6 0.77 1.1 0.61
1 .0 x 1 0 ““* 2.1 0.47 1.6 0.74 1.2 0.38
1 .0 x 1 0 ? 2.0 0.43 1.7 0.73 1.3 0.59
1 .0 x 1 0 “? 1.8 0.42 1.7 0.71 1.3 0.58
1 .0 x 1 0 * 1.8 0.39 1.7 0.67 1.7 0.51
1 .0 x 1 0 ” 4.0 0.21 4 0.46 3.3 0.29
0.5x10* 18.6 0.16 15.9 0.18 11.4 0.17
1 .0 x 1 0 * 28.3 0.17 24.1 0.2 21.8 0.2
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13“ P a n crea s
AP PA LAT
(MeV) Dt/ ^ U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10'® 1.6 3.34 1.1 3.81 0.6 5.26
1.0x10® 1.7 3.19 1.4 3.62 0.7 5.02
1.0x10“? 1.9 3 1.5 3.31 0.7 4.46
1.0x10“® 2.2 2.76 1.9 3.13 0.7 4.8
1.0x10“® 2.5 2.67 2.0 2.98 1.1 4.43
1.0x10““* 2.4 2.58 2.1 2.88 1.2 2.69
1.0x10“? 2.7 2.29 2.3 2.79 1.2 4.08
1.0x10“? 2.7 2.21 2.5 2.71 1.3 4.04
1.0x10“! 2.9 2.09 2.6 2.58 2.3 3.45
1.0x10“ 4.3 1.42 3.6 1.81 3.2 2.49
0.5x10* 15.7 0.54 11.6 0.59 9.8 0.66
1.0x10* 27.2 0.62 19.7 0.65 17.1 0.7
[renais
AP PA LATJcineigy
(MeV) Dt/O U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10“® 0.8 11.41 1.1 8.65 0.6 9.92
1.0x10“® 0.9 10.33 1.2 8.6 0.7 9.5
1.0x10“? 0.9 10.21 1.4 8.23 0.7 9.01
1.0x10“® 1.1 9.41 1.6 7.33 0.8 9.78
1.0x10“® 1.2 9.09 1.7 7.63 1.0 9.6
1.0x10““* 1.4 8.72 1.8 7.41 1.2 5.96
1.0x10? 1.6 7.43 1.9 7.01 1.3 8.54
1.0x10“? 1.8 7.49 2.3 6.64 1.3 8.13
1.0x10“* 1.8 7.01 2.7 6.35 1.5 7.06
1.0x10“ 3.5 5.28 4.4 4.09 3.3 5.23
0.5x10* 10.8 1.28 14.2 1.21 7.7 1.27
1.0x10* 20.0 1.31 26.7 1.24 15.6 1.38
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15“ K id n eys
Energy
(MeV)
AP PA LAT
Dt/O U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10“® 1.2 1.87 1.8 0.9 0.6 1.13
1.0x10“® 1.5 1.84 2.1 0.85 0.7 1.06
1.0x10“? 1.5 1.66 2.4 0.79 0.9 0.97
1.0x10“® 1.8 1.51 2.7 0.75 1.2 1.05
1.0x10“® 1.9 1.41 2.8 0.72 1.5 1.01
1.0x10““* 2.1 1.36 2.8 0.7 1.6 0.62
1.0x10“? 2.1 1.19 2.5 0.69 1.6 0.95
1.0x10“? 2.1 1.15 2.3 0.68 1.7 0.96
1.0x10“* 2.0 1.08 2.1 0.65 1.8 0.82
1.0x10” 8.3 0.77 4.1 0.37 2.3 0.5
0.5x10* 11.3 0.27 16.7 0.23 9.5 0.27
1.0x10* 22.4 0.29 29.7 0.24 17.4 0.31
id d er
Energy
(MeV)
AP PA LAT
Dt/O U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10“® 1.9 1.3 1.2 2.09 0.7 2.06
1.0x10“® 2.0 1.23 1.2 2.03 0.8 2.03
1.0x10“? 2.1 1.13 1.4 1.9 1.0 1.92
1.0x10® 2.2 1.05 1.5 1.76 1.0 2.12
1.0x10“® 2.2 1.02 1.6 1.7 1.2 2.03
1.0x10““ 2 1.01 1.7 1.65 1.5 1.25
1.0x10“? 1.9 0.9 1.7 1.58 1.5 1.89
1.0x10“? 1.8 0.89 1.7 1.55 1.5 1.91
1.0x10“* 2.0 0.83 1.7 1.47 1.6 1.63
1.0x10“ 3.9 0.41 3.7 1.05 2.6 1.07
0.5x10* 15.4 0.26 12.6 0.33 8.0 0.38
1.0x10* 27.9 0.29 20.4 0.36 18.2 0.42
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17- R ectu m
AP PA LAT
(MeV) Dt/^> U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10“® 1.3 3.56 0.7 1.77 1.1 3.45
1.0x10“® 1.4 3.39 0.8 1.72 1.2 3.33
1.0x10“? 1.6 3.22 0.9 1.63 1.2 3.28
1.0x10“® 1.6 2.9 1.1 1.56 1.3 3.6
1.0x10“® 1.7 2.76 1.1 1.51 1.4 3.38
1.0x10““ 1.9 2.68 1.2 1.5 1.5 2.14
1.0x10“? 2.4 2,35 1.2 1.48 1.7 3.19
1.0x10“? 3.6 2.28 1.7 1.43 1.9 3.16
1.0x10“* 3.9 2,18 2 1.35 2.7 2.72
1.0x10“ 5.7 1.51 3.6 0.71 4.1 1.99
0.5x10* 17.1 0.5 10.4 0.43 12.3 0.56
1.0x10* 24.7 0.53 18.9 0.46 20.5 0.59
s te s
AP PA LATü n ei gy  
(MeV) Dt/O U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10“® 2.1 1.3 1,4 3.92 0.7 2.66
1.0x10® 2.3 1.28 1.6 3.91 0.9 2.57
1.0x10“? 2.5 1.3 1.7 3.97 1,1 2.46
1.0x10® 2.5 1.38 1.8 3.85 1.1 3
1.0x10“® 2.7 1.43 1.7 3.86 1.0 2.89
1.0x10““ 2.8 1.52 1.6 3.74 1.0 1.98
1 .0x10? 2.8 1.39 1.6 3.79 0.9 3.02
1 .0x10? 3.1 1.3 1.6 8.67 0.9 3.06
1.0x10* 3.2 0.71 2.1 3.36 1.9 2.29
1.0x10“ 10.1 0.39 7.9 1.87 6.5 0.98
0.5x10* 27.7 0.33 23.7 0.56 17.3 0.52
1.0x10* 43.9 0.38 40.3 0.58 34.4 0.57
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Appendix F
Absorbed dose per unit fluence D^/O [pGy and statistical uncertainty U  
( 9  ^ from monoeneigetic neutrons under various orientations for Zubal complete 
phantom.
1- S k in
Energy • 
(MeV)
AP PA LAT
Dt/ ^ U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10“® 0.532 0.3 0.333 0.1 0.236 0.2
1.0x10“® 0.503 0.2 0.268 0.1 0.197 0.1
1.0x10“? 0.512 0.3 0.197 0.2 0.16 0.3
1.0x10“® 0.527 0.5 0.16 0.4 0.137 0.2
1.0x10“® 0.489 0.6 0.134 0.4 0.115 0.5
1.0x10““ 0.424 0.5 0.111 0.4 0.096 0.5
1.0x10“? 0.414 0.5 0.121 0.4 0.101 0.2
1.0x10“? (1838 0.5 0.365 0.3 0.302 0.2
1.0x10“* 4,947 0.4 2.345 0.4 2.043 0.2
1.0x10“ 29.175 0.5 12.733 0.3 11.953 0.6
0.5x10* 76.489 0.5 47.296 0.4 46.951 0.2
1.0x10* 103.222 0.4 72.794 0.2 70.959 0.2
2.0x10* 137.035 0.4 110.707 0.1 105.494 0.2
2- B ra in
Energy
(MeV)
AP PA LAT
D t/ O  U  (%) D t/ O  U (%) D t/ O  U  (%)
1.0x10"^ 0.024 0.5 0.05 0.4 0.039 0.3
1.0x10"® 0.032 0.3 0.069 0.4 0.054 0.2
1.0x10"^ 0.059 0.3 0.134 0.4 0.104 0.1
1.0x10"® 0.1 0.4 0.244 0.4 0.172 0.1
1.0x10"® 0.123 0.5 0.306 0.4 0.204 0.1
1.0x10"^ 0,128 0.4 0.326 0.4 0.207 0.2
1.0x10"® 0.131 0.4 0.333 0.4 0.205 0.2
1.0x10"^ 0.15 0.3 0.357 0.4 0.232 0.1
1.0x10"^ 0.405 0.3 0.856 0.5 0.705 0.1
1.0x10° 4.612 0.3 10.236 0.5 7.092 0.3
0.5x10^ 43.451 0.3 59.545 0.4 44.501 0.1
1.0x10^ 69.052 0.3 86.706 0.4 68.142 0.1
2.0x10^ 107.628 0.2 123.329 0.1 103.646 0.1
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3- B o n e
AP PA LAT
(MeV) Dt/O U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10® 0.092 0.3 0.042 0.1 0.042 0.2
1.0x10”® 0.126 0.2 0.058 0.1 0.057 0.1
1.0x10”? 0.228 0.2 0.106 0.1 0.096 0.1
1.0x10”® 0.381 0.2 0.181 0.1 0.14 0.1
1.0x10”® 0.458 0.3 0.221 0.1 0.155 0.1
1.0x10”“ 0.47 0.2 0.231 0.1 0.152 0.2
1.0x10”? 0.466 0.2 0.232 0.1 0.146 0.2
1.0x10”? 0.486 0.3 0.242 0.1 0.152 0.1
1.0x10”* 0.972 0.3 0.399 0.1 0.311 0.1
1.0x10° 9.711 0.3 2.943 0.2 2.296 0.3
0.5x10* 48.548 0.3 29.529 0.3 22.847 0.2
1.0x10* 70.658 0.3 49.631 0.2 39.592 0.2
2.0x10* 102.598 0.2 83.112 0.1 68.234 0.1
e le ta l m u sc le
Energy ■ 
(MeV)
AP PA LAT
Dt/O U(% ) Dt/O U(% ) Dt/O U(% )
1.0x10”® 0.629 0.1 0.574 0.1 0.345 0.1
1.0x10”® 0.695 0.1 0.643 0.1 0.376 0.1
1.0x10”? 0.915 0.1 0.865 0.1 0.487 0.1
1.0x10”® 1.19 0.1 1.152 0.1 0.619 0.1
1.0x10”® 1.263 0.1 1.236 0.1 0.644 0.1
1.0x10”“ 1.202 0.1 1.174 0.1 0.605 0.1
1.0x10”? 1.12 0.1 1.093 0.1 0.559 0.1
1.0x10”? 1.091 0.1 1.069 0.1 0.543 0.1
1.0x10”* 1.621 0.1 1.626 0.1 0.858 0.1
1.0x10° 7.349 0.1 7.674 0.1 4.117 0.1
0.5x10* 30.547 0.1 31.134 0.1 19.166 0.1
1.0x10* 45.000 0.1 45.583 0.1 30.059 0.1
2.0x10* 62.896 0.1 63.292 0.1 44.963 0.1
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5- L u n gs
Energy ■ 
(MeV)
AP PA LAT
D t/ ^ U(% ) D t/ O U(% ) D t/O U(% )
1.0x10”® 0.326 0.5 0.333 0.4 0.457 0.3
1.0x10”® 0.392 0.3 0.410 0.3 0.566 0.2
1.0x10”? 0.612 0.3 0.656 0.3 0.900 0.2
1.0x10”® 0.944 0.4 1.017 0.4 1.338 0.2
1.0x10”® 1.075 0.4 1.174 0.4 1.516 0.1
1.0x10”“ 1.078 0.3 1.173 0.4 1.495 0.3
1.0x10”? 1.038 0.3 1.138 0.4 1.426 0.3
1.0x10”? 1.021 0.3 1.102 0.4 1.361 0.2
1.0x10”* 1.364 0.3 1.283 0.3 1.435 0.2
1.0x10“ 6.796 0.2 5.265 0,2 2.154 0.3
0.5x10* 33.743 0.2 31.386 0.2 13.791 0.1
1.0x10* 49.210 0.2 46.645 0.2 25.087 0.1
2.0x10* 67.695 0.1 65.484 0.1 40.140 0.1
6- Eye
Energy ■ 
(MeV)
AP PA LAT
D t/€» U(% ) D t/O U(% ) D t/ O U(% )
1.0x10'^ 0.637 0.2 0.403 0.1 0.329 0.2
l.GxlQ-® 0.790 0.2 0.493 0.1 0.397 0.1
1.0x10“^ 1.156 0.2 0.773 0.1 0.593 0.1
1.0x10“^ 1.540 0.2 1.178 0.1 0.813 0.1
1.0x10“® 1.630 0.2 1.359 0.1 0.872 0.1
1.0x10^ 1.557 0.1 1.357 0.1 0.832 0.2
1.0x10“® 1.486 0.1 1.316 0.1 0.781 0.1
1.0x10“^ 1.736 0.2 1.277 0.1 0.848 0.2
1.0x10“^ 4.848 0.6 1.361 0.1 2.120 0.3
1.0x10° 21.624 0.7 1.548 0.4 12.211 1.1
0.5x10^ 46.266 0.8 11.147 0.8 38.664 0.4
1.0x10^ 61.387 0.7 21.358 0.7 53.379 0.4
2.0x10^ 76.264 0.6 36.548 0.4 70.810 0.4
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7- L iver
AP PA LATiin erg y  ■ 
(MeV) D t/ O U (% ) D t/O U (% ) D t/ O U (% )
1 .0 x 1 0 “^ 0.554 0.1 0.515 0.1 0.269 0.1
1 .0 x 1 0 “® 0.666 0.1 0.627 0.1 0.317 0.1
1 .0 x 1 0 “^ 1.015 0.1 0.967 0.1 0.470 0.1
1 .0 x 1 0 “® 1.498 0.1 1.438 0.1 0.667 0.1
1 .0 x 1 0 “® 1.706 0.1 1.636 0.1 0.740 0.1
1 .0 x 1 0 “"^ 1.704 0.1 1.173 0.1 0.725 0.1
1 .0 x 1 0 “® 1.645 0.1 1.554 0.1 0.688 0.1
1 .0 x 1 0 “^ 1.602 0.1 1.502 0.1 0.655 0.1
1 .0 x 1 0 “^ 1.876 0.1 1.618 0.1 0.681 0.1
1 .0 x 1 0 ° 6.007 0.3 3.198 0.2 0.842 0.2
0.5x10^ 30.328 0.8 21.819 0.3 8.803 0.2
1.0x10^ 45.483 0.3 36.168 0.2 18.391 0.1
2 .0 x 1 0 1 63.339 0.1 55.214 0.2 33.647 0.1
8- K id n eys
E nergy
(MeV)
AP PA LAT
D t/ O  U (%) D t/ O  U (%) D t/ O  U (%)
1.0x10“^ 0.542 0.3 0.446 0.2 0.204 0.4
1.0x10“® 0.657 0.2 0.627 0.2 0.234 0.2
1.0x10“^ 1.029 0.2 0.916 0.2 0.344 0.3
1.0x10“® 1.559 0.2 1.476 0.3 0.498 0.2
1.0x10“® 1.810 0.3 1.759 0.3 0.574 0.1
1.0x10“^ 1.836 0.2 1.816 0.2 0.725 0.3
1.0x10“® 1.800 0.2 1.813 0.2 0.583 0.3
1.0x10“^ 1.775 0.2 1.814 0.2 0.580 0.3
1.0x10“^ 1.921 0.2 2.082 0.2 0.642 0.2
1.0x10° 2.503 0.2 6.268 0.3 1.067 0.4
0.5x10^ 18.916 0.3 33.412 0.3 10.167 0.2
1.0x10^ 33.531 0.2 49.485 0.3 19.577 0.2
2 .0x10^ 52.958 0.2 68.214 0.1 33.510 0.2
132
9 - O eso p h a g u s
E nergy  ■ 
(MeV)
AP PA LAT
Dt/O U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10”® 0.845 1.1 0.106 1.9 0.482 1.1
1.0x10”® 0.990 0.7 0.133 1.7 0.571 0.6
1.0x10”? 1.319 0.7 0.208 1.6 0.814 0,7
1 .0x10”® 1.610 0.9 0.333 1.9 1.096 0.7
1.0x10”® 1.585 1.1 0.410 1.8 1.151 0.4
1 .0x10”“ 1.413 0.9 0.424 1.6 1.069 1.0
1.0x10”? 1.247 1.0 0.441 1.4 0.980 1.1
1.0x10”? 1.1260 0.9 0.442 1.4 0.885 0.9
1.0x10”* 1.1290 0.9 0.543 1.4 0.896 0.8
1.0x10" 2.992 0.6 2.644 1.3 1.088 1.0
0.5x10* 26.010 0.4 24.464 0.8 11.555 0.4
1.0x10* 40.953 0,4 38.211 0.5 22.453 0.3
2 .0x10* 59.758 0.4 56.749 0.2 37.746 0.3
lo -  Stom ach
E nergy  ■ 
(MeV)
AP PA LAT
D t/ O U (% ) D t/ O  U  (%) D t/O U (% )
1.0x10”® 0.686 0.2 0.365 0.3 0.109 0.6
1.0x10”® 0.845 0.2 0.450 0.3 0.128 0.3
1.0x10”? 1.351 0.3 0.717 0.4 0.197 0.4
1.0x10”® 2.082 0.3 1.136 0.4 0.308 0.3
1.0x10”? 2.434 0.2 1.362 0.4 0.370 0.2
1.0x10”“ 2.495 0.2 1.421 0.3 0.394 0.5
1.0x10”? 2.476 0.2 1.414 0.3 0.398 0.4
1.0x10”? 2.465 0.4 1.430 0.3 0.409 0.3
1.0x10* 2.888 0.5 1.642 0.4 0.519 0.3
1.0x10" 7.482 0,4 2.703 0.5 3.008 0.5
0.5x10* 33.152 0.4 19.314 0.5 25.584 0.2
1.0x10* 48.742 0.4 33.061 0.2 40.013 0.2
2 .0x10* 66.220 0.2 52.476 0.2 59.699 0.1
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11- S m a ll in te s t in e s
E nergy  ■ 
(MeV)
AP PA LAT
Dt/ ^ U (% ) Dt/ ^ U (% ) Dt/O U (% )
1.0x10"® 0.417 0.5 0,604 0.4 0.219 0,7
1.0x10"® 0.497 0,6 0,745 0.3 0.254 0.4
1.0x10"? 0.766 0,4 1,201 0,3 0,384 0,4
1.0x10"® 1.169 0,4 1.913 0,4 0,582 0.2
1.0x10"? 1,409 0,4 2.274 0.4 0.690 0.5
1.0x10"“ 1.498 0.5 2.369 0.4 0,727 0,5
1.0x10"? 1,511 0,4 2.353 0,4 0,734 0.4
1.0x10"? 1.553 0.4 !&866 0.4 0.743 0,3
1.0x10'* 1,894 0,3 2.62 0.4 0.908 0,3
1.0x10° 6,985 0.3 3,501 0.4 3.539 0.1
0.5x10* 34,767 0,2 20,413 0.3 25.546 0.1
1.0x10* 51.04 0,2 35,331 0,2 40.26 0,1
2 .0x10* 69.222 0.2 54,743 0,2 60,149 0.1
>lon
E nergy  ■ 
(MeV)
AP PA LAT
Dt/O U (% ) Dt/<E> U (% ) Dt/O U (% )
1.0x10"® 0,520 1,0 0.411 0,9 0,210 1,4
1.0x10"® 0.646 0,6 0,521 0.8 0.243 0,7
1.0x10"? 1.064 0,6 0,866 0,9 0.364 0,9
1.0x10"® 1.686 0.7 1.396 0.9 0.555 0.8
1.0x10"? 1,995 0.8 1,693 0.8 0.646 0.5
1.0x10"“ 2.12 0.6 1,764 0,7 0,660 1,1
1.0x10"? 2.145 0.6 1.824 0.7 0,674 1,1
1.0x10"? 2,177 0.6 1,849 0,7 0,689 0,9
1.0x10“* 2.734 0,5 2.100 0,5 0,862 0,7
1.0x10“ 9,089 0,2 3,209 0.3 2.987 0.4
0.5x10* 36.732 0.2 19,561 0.2 19.121 0.1
1.0x10* 53.036 0,2 33,883 0.1 31,598 0.1
2 .0x10* 70.916 0.2 53,076 0,1 49,544 0,1
134
13- P a n crea s
AP PA LATjin e rg y  ■ 
(MeV) D t/O U (% ) D t/O U (% ) D t/ O U (% )
1.0x10'® 0.698 0.6 0.305 0.3 0.326 0.3
1.0x10'® 0.876 0.4 0.377 0.7 0.383 0,7
1.0x10'? 1.385 0.4 0.596 0,6 0,596 0,4
1.0x10'® 2.158 0.4 0,962 0.6 0.929 0.4
1.0x10'? 5L518 0.5 1.144 0,7 1.097 0,4
1.0x10 '“ 2.594 0.4 1.195 0.7 1.136 0.2
1.0x10'? 2.569 0.4 1.223 0.6 1.148 0,5
1.0x10'? 2.574 0.3 1.256 0.6 1,138 0,5
1.0x10'* 2.828 0.3 1,461 0,6 1,285 0.4
1.0x10“ 4.671 0.4 2,674 0,5 1,991 0.4
0.5x10* 27.848 0.6 21,928 0.6 17.678 0,6
1.0x10* 43.707 0.6 36.62 0,7 31,459 0.4
2 .0x10* 62.745 0.6 56.187 0,7 50.662 0.3
14- A d ren a ls
E nergy
(MeV)
AP PA  LAT
D t/ O  U (% ) D t/ O  U (%) D t/ O  U (% )
1.0x10"® 0,695 0.4 0,315 0,4 0,331 0.7
1.0x10"^ 0.846 0.2 0.383 0,3 0,393 0.4
1.0x10"^ 1.330 0.2 0,604 0,3 0,605 0.2
1.0x10"® 2,067 0,3 0.942 0,4 0,931 0.3
1.0x10"® 2,424 0,3 1.133 0.4 1,089 0,2
1.0x10""^ 2,522 0.3 1,179 0,4 1,118 0,1
1,0x10"® 2.510 0,3 1,202 0,3 1,114 0.3
1.0x10"^ 2,501 0.2 1,233 0,3 1.103 0.3
1.0x10"^ 2,754 0.2 1,452 0,3 1,223 0,3
1.0x10° 3,637 0.6 3.310 1,3 1,529 0,2
0,5x10^ 22.798 1,1 26,323 1.3 9,895 0,8
1.0x10^ 38.303 1 41,592 1.3 20.098 1
2 .0x10^ 57,668 0.9 61.394 0,6 34.891 0.8
135
15- R ed  b o n e  m a rro w
E nergy  ■ 
(MeV)
AP PA LAT
D t/O U (% ) D t/ O U (% ) D t/O U (% )
1.0x10“® 0.738 0.3 0.315 0,3 0,234 0.4
1.0x10“® 0.912 0,2 0.388 0.3 0,277 0,2
1.0x10“^ 1.330 0.2 0,616 0.3 0.424 0.3
1.0x10"® 2.226 0.3 0,980 0.4 0.644 0,2
1.0x10"® 2.424 0,3 1,179 0.3 0.746 0,2
1.0x10"^ 2,633 0.2 1.238 0,3 0.757 0.3
1.0x10"® 2.589 0.2 1,262 0,3 0,745 0.3
1.0x10"^ 5L668 0.2 1.291 0,3 0,735 0.3
1.0x10"^ 2.870 0,2 1,541 0.3 0.855 0.2
1,0x10° 5,617 0,1 4.769 0.2 1,996 0,3
0,5x10^ 28,291 0,1 29,760 0.2 14.446 0.1
1 .0x10^ 43,560 0,1 44,497 0.1 24.955 0,1
2 .0x10^ 63,966 0.1 65.381 0,1 41.033 0.1
16- T h yro id s
E nergy  ■ 
(MeV)
AP PA LAT
D t/ O U (% ) D t/ O U (% ) D t/O U (% )
1.0x10“® 0.575 1,1 0,353 1.1 0.236 1,4
1.0x10“® 0,710 0.7 0.435 1 0.274 0,7
1.0x10“? 1.134 0.7 0,706 0.9 0.422 0.9
1.0x10“® 1.812 0,8 1,127 1.1 0.652 0.8
1.0x10"? 2.205 0.9 1,345 1.1 0.768 0.5
1.0x10““ 2,347 0.7 1,429 1 0.809 1.1
1.0x10“? 2,357 0.7 1,484 0.9 0.836 1.1
1.0x10“? 2.405 0.6 1.516 0,9 0,855 0.8
1.0x10“* 3.039 0.6 1,784 0,9 1,016 0.7
1.0x10“ 11,434 0,9 3.587 1.1 1.782 1,2
0.5x10* 42.65 1,2 24.138 1.2 10,139 1
1.0x10* 58.005 1,1 38,115 1.2 18.687 0.8
2 .0x10* 76.569 1.1 55.590 0.6 30,659 0.7
136
17- T ra ch ea
AP P A  LAT
(M eV) Dt/O U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10"® 0.476 2.6 0,442 1.9 0.192 3.1
1.0x10"® 0.610 1.7 0.538 1.8 0,215 0.7
1.0x10"^ 0.944 1.6 0.885 2.1 0,343 1,9
1.0x10"® 1.420 1.8 1.442 2 0,530 1,8
1.0x10"® 1,776 2 1.740 1,9 0.625 1,1
1.0x10"^ 1.882 1.6 1.864 1.7 0,639 2,5
1.0x10"® 1.899 1.6 1.903 1,7 0.674 2,4
1.0x10"^ 2.405 1,4 1.894 1.6 0.662 1.9
1.0x10"^ 2.522 1.2 2.284 1,0 1,037 1,2
1.0x10° 9,771 0.5 4.420 0,5 5,586 0,9
0.5x10^ 38.728 0.5 26,354 0,5 25,13 0.3
1.0x10^ 54,584 0.5 41,128 0,2 37.667 0.3
18- S p lee n
E nergy  • 
(MeV)
AP PA LAT
D t/O U (% ) D t/ O  U (%) D t/O U (% )
1 .0x10“® 0.499 0,3 0.486 0.3 0.233 0,4
1.0x10“® 0.602 0,2 0.603 0.2 0.275 0,2
1.0x10“? 0.932 0.2 0.974 0.2 0,417 0.2
1.0x10“® 1.432 0,2 1,564 0.3 0.630 0,2
1.0x10“® 1,694 0.3 1.882 0.3 0.742 0,1
1.0x10““ 1,760 0.2 1.964 0.3 0.769 0.3
1.0x10“? 1.761 0,2 1.976 0.2 0.774 0.3
1.0x10“? 1.786 0,2 1.991 0,2 0.782 0.2
1.0x10“* 2.025 0.2 2.356 0.2 0.958 0.2
1.0x10“ 3.954 0,2 6.802 0,4 3.052 0,5
0.5x10* 23.362 0.3 33.182 0,5 20.964 0.2
1.0x10* 38.016 0.4 49.098 0.5 33.989 0.2
2 .0x10* 56,017 0.4 68.206 0.2 50.922 0.1
137
19- T este s
E nergy  - 
(MeV)
AP PA LAT
Dt/O U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10"® 0.870 1,7 0.319 2,1 0.297 2.3
1.0x10“® 1.054 1.1 0.400 1.9 0,335 1.3
1.0x10"^ 1.668 1.0 0,654 1.8 0,489 1,6
1.0x10® 2.497 1.2 1.038 2,2 0.699 1,5
1.0x10"® 2.915 1.4 1,237 2.1 0.801 0,9
1.0x10""^ 2.781 1.2 1,306 2.0 0,817 2,1
1.0x10"® 2.718 1.2 1.360 1,8 0.773 2,1
1.0x10"^ 2,810 1.0 1,327 1,8 0.843 1.6
1.0x10"^ 5.011 0.8 1.712 1.6 1,281 1.0
1.0x10° 19.030 0.7 3,170 1,7 4.502 1,6
0.5x10^ 45,317 0.8 17,548 1,0 23,169 0.4
1.0x10^ 61,277 0,7 31,952 0.8 37,486 0,4
2.0x10^ 76.088 0.6 51,346 0,3 56.107 0,3
2 0 - Rectum
E nergy  ■ 
(MeV)
AP PA LAT
Dt/ ^ U (% ) Dt/O U (% ) Dt/O U (% )
1.0x10“® 0,647 0,9 0.338 0,9 0.37 0,9
1.0x10“® 0.774 0,6 0.420 0.8 0.446 0,5
1.0x10“? 1,23 0,6 0,694 0.7 0.686 0,6
1.0x10“® 1,881 0.7 1.155 0.9 1.004 0,6
1.0x10“® 2,210 0,8 1,406 0.8 1.149 0.4
1.0x10““ 2.178 0,6 1,472 0.8 1.143 0.8
1.0x10“? 2.122 0.6 1.498 0,7 1.086 0.8
1.0x10“? 2.057 0,6 1.517 0,7 1,045 0.7
1.0x10“* 2.181 0,6 1.924 0.6 1.082 0.6
1.0x10" 2.698 0.5 7,207 0.7 1.265 0,8
0.5x10* 19.977 0,5 34.556 0.7 12,902 0.4
1.0x10* 35.098 0,4 50,891 0.7 24.645 0,3
2.0x10* 54,733 0.4 68.961 0.2 41.146 0.3
138
21- B la d d er
E nergy  ■ 
(MeV)
AP PA LAT
Dt/O U (% ) Dt/O  U  (%) Dt/O U (% )
1.0x10“® 0.564 0.6 0.584 0.5 0.424 0.6
1.0x10"® 0.672 0.4 0.710 0.4 0.496 0.3
1.0x10"^ 1.015 0.4 1.112 0.4 0.748 0.4
1.0x10"® 1.526 0.5 1.735 0.5 1.086 0.4
1.0x10"® 1.833 0.5 2.054 0.5 1.252 0.2
1.0x10“"^ 1.902 0.4 2.098 0.5 1.271 0.5
1.0x10“® 1.915 0.4 2.072 0.5 1.263 0.5
1.0x10“^ 1.924 0.4 51053 0.5 1.24 0.4
1.0x10“^ 2.369 0.3 2.235 0.5 1.336 0.4
1.0x10° 9.139 0.3 2.971 0.4 1.970 0.5
0.5x10^ 38.052 0.4 19.164 0.4 16.005 0.3
1.0x10^ 54.617 0.3 33.958 0.4 28.870 0.2
2 .0x10^ 72.808 0.3 53.442 0.2 46.643 0.2
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